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This thesis consists of two volumes submitted towards the Doctorate in Clinical Psychology. 
 
Volume I consist of three research chapters. The first chapter presents a systematic review of 
the literature reporting outcomes for people living with a mental illness when diagnosed with 
cancer. People with comorbid mental illness and cancer were found to have a poor cancer 
outcome compared to the general population, beginning with the lack of use of cancer 
screening services and ending with an increased likelihood of cancer mortality. The second 
chapter is an empirical research study reporting the feasibility of conducting a trial of a 
psychological prehabilitation intervention for patients diagnosed with sarcoma. Nine 
participants were recruited and randomised to the control or experimental arm of study, they 
completed measures before and after their surgery (and intervention for those in the 
experimental arm). The results highlight that the trial is feasible to conduct, and the measures 
used were sensitive to the changes that sarcoma patients undergo, however, a number of 
modifications are suggested to improve the control of a larger study in addition to the success 
of recruitment. The third chapter consists of two public dissemination documents that offer 
an overview of the systematic review and empirical paper in a manner that is both brief and 
accessible for the general public. 
 
Volume II consists of five clinical practice reports. The first report presents the case of 
Margaery1, a 51-year old lady living with a diagnosis of schizophrenia presenting with 
intrusive thoughts. Two formulations are presented: A cognitive behavioural formulation of 
intrusive thoughts in the context of obsessive-compulsive disorder and a psychodynamic 
formulation are presented to understand the distress that Margaery experiences. The second 
report presents a service evaluation of staff members perceptions of the current pathway for 
clients diagnosed with emotionally unstable personality disorder in a local adult mental 
health community service. The third report presents the case of Alfred, a 65-year old man 
being treated in a local older adult inpatient ward, presenting with symptoms of a panic 
disorder. Alfred’s distress is formulated within a cognitive behavioural therapy(CBT) 
formulation. A CBT intervention, including graded exposure, is then described and analysed 
using a single case A-B design. The fourth report describes the case of Daisy, a 26-year old 
 
1  All client’s names have been changed to maintain their anonymity. 
 
   
female diagnosed with a mild learning disability, who presented with difficulties with 
interpersonal difficulties and health anxieties. A formulation informed by cognitive analytic 
therapy(CAT) is presented along with a CAT informed intervention. The final report 
describes the case of Jess, a 13-year old female presenting to a local child and adolescent 
mental health service with symptoms of generalised anxiety. Three formulations are 
presented: cognitive behavioural therapy, in addition to a systematic formulation and a 
psychodynamic formulation, which were used to reformulate the case are presented. The 
beginning of an anxiety management intervention is described, and the outcomes obtained 
during the time of intervention. 
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Abstract 
 
Background: The diagnosis of a cancer has a number of physical and emotional impacts on 
an individual. NICE (2004) published guidance highlighting the need for the psychological 
wellbeing of cancer patients in routine practice. However, there is little consensus, within the 
literature, of how those who have a mental illness pre-existing their cancer are cared for. 
Research suggests that people with a mental illness experience disparity in care when living 
with a number of comorbid health conditions. 
 
Aim: The aim of the present review is to collate and systematically evaluate the literature on 
cancer outcomes in people with a pre-existing mental illness. 
 
Method: Six databases were systematically searched for published empirical research 
concerning cancer and pre-existing mental illness. Twenty-Eight papers were selected for 
review upon fulfilling the inclusion and exclusion criteria. Each paper was evaluated for their 
methodological quality using standardised quality measures. 
 
Results: People living with comorbid mental illness and cancer experience disparities in their 
care from the beginning of their cancer journey through to the end. People with a pre-existing 
mental illness were found to be diagnosed later, which is attributable to the lack of detection 
of cancer symptoms and use of cancer screening services. This resulted in higher cancer 
related case fatalities, when compared to the general population. Furthermore, in mainstream 
services, cancer patients are less likely to receive recommended cancer treatments. 
Exceptions to these findings are found in veteran healthcare settings. 
 
Conclusions: A number of high-power epidemiological papers evidence that cancer 
outcomes for people with a mental illness is poor. There are limited number of prospective, 
longitudinal and experiential papers in the present literature. These papers are needed to 
further understand the identified disparities and to begin to make progress in this area. 
  
 




i) The Experience of Cancer 
 
‘Cancer’ is an umbrella term, for almost 200 different diseases characterised by abnormal 
cells dividing in an uncontrolled way (Cancer Research UK, N.D). The lifetime prevalence of 
getting a cancer is 1 in 2 (Cancer Research UK, N.D) and is accountable for 42% of deaths of 
people under 75 in the UK (Department of Health, 2014). 
 
Previous literature has described the cancer journey for patients (Hayes et al., 2008; Mistry, 
Wilson, Priestman, Damery & Haque, 2010); the journey is characterised by detection of the 
cancer via screening or detection of an abnormal physiological symptom, followed by 
investigations to contribute towards a diagnosis, then medical treatments to address the 
cancer and finally there is a cancer outcome which may be remission, survivorship (if cancer 
free for 5 years) or for some, death. For clarity, the journey has been described here as a set 
on linear events, however, the process can be unfixed to a procedural structure (Schildmeijer, 
Frykholm, Kneck & Ekstedt, 2019). 
 
Lung, breast, prostate and bowel cancer are the most common forms of cancer in the world; 
with breast cancer being the most common in females and prostate cancer being the second 
most common cancer in males (Smittenaar, Petersen, Stewary & Moitt, 2016; Bray et al., 
2018). Survival rates for all cancers are improving (Smittenaar et al., 2016) with breast 
cancer and prostate cancer having relatively good rates of survival, whilst lung cancer and 
brain tumours have poor rates of survival (Cancer Research UK, N.D).  Estimates of cancer 
incidence highlights that as a consequence of an ageing population and health issues such as 
obesity both cancer incidence and number of deaths will increase by 2035, however, 
mortality rates will improve (Mistry, Parkin, Ahmad & Sasieni, 2011; Smittenaar et al., 
2016). This reduction in the rate of mortality has been seen since 1993 in breast cancer 
patients (Smittenaar et al., 2016) with causes for this decrease being attributed to better 
screening, which leads to cancers being treated before the cancer is classified as stage 4 
(McPhail, Johnson, Greenberg, Peake & Rous, 2015). 
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Cancer patients report an increased incidence of anxiety (Maddineni, Lau & Sangar, 2011; 
Mitchell et al., 2011; Vehling et al., 2012; Ford, Catt, Chalmers & Fallowfield, 2012), 
depression (Mitchell et al., 2011; Walker et al., 2012; Ford et al., 2013; Yang et al., 2013), 
fear of cancer reoccurrence (Simard & Savard, 2009; Puts, Papoutis, Springall & 
Tourangeau, 2012; Swash, Hulbert-Williams & Bramwell, 2014), post-traumatic stress 
disorder (Koutrouli, Anagnostopoulos & Potamianos, 2012) and decisional regret (Chambers, 
Hyde, Ip, Dunn & Gardiner, 2013). In addition to these emotional issues’, cancer patients 
report issues in sexual functioning (Lammerink, De Bock, Pras, Reyners & Mourits, 2012; 
Krychman, 2012; Moran et al., 2013), cognitive functioning (Koopelmans, Breteler, Boogerd, 
Seynaeve & Schagen, 2013) and socioeconomic status (Kimman et al., 2012). However, 
these issues can vary  from patient to patient with factors such as age (Howard-Anderson, 
Ganz, Bower & Stanton, 2012; Hess & Chen, 2014), education level (Kourtrouli et al., 2012; 
Koch, Jansen, Brenner and Arndt, 2013), income (Jansen, Koch, Brenner & Arndt, 2010; 
Koutrouli et al., 2012), ethnicity and culture (Koch et al., 2013), number of children (Fiszer, 
Dolbeault, Sultan & Bredart, 2014) and personality (Crist & Grunfeld, 2013; Sales, Carvalho, 
McIntyre, Pavlidis & Hyphantis, 2014) being factors that moderate elevated distress in cancer 
patients. 
 
Thus, it is understood that there are more health implications to consider than just the 
cancerous cell, with emotional distress now being assessed routinely alongside pulse, 
respiration, blood pressure, temperature and pain (Bultz & Holland, 2006). 
 
ii) The Psychological Impact of Cancer 
 
Over the 20th Century, advances in medicine meant that the detection, treatment and survival 
of cancer was increasing and so the view of cancer as a death sentence was beginning to shift 
(Holland, 2018). With this newly generated optimism around cancer, focus has now been 
placed on wellbeing whilst living with cancer.  
 
As afore mentioned, there are a large number of emotional and psychological issues that arise 
for patients during their cancer journey. Owing to the well-understood psychological impact 
of cancer, NICE have formally acknowledged the expectation that an individual’s 
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psychological wellbeing should be taken into account throughout their cancer journey (NICE, 
2004).  
 
The publication of the NICE guidance saw a move towards psychological awareness being 
embedded into the oncology culture and psychological care being offered by all staff 
members; Bultz and Holland (2006) describe how emotional distress is now seen as the 
“sixth vital sign” due to it being routinely assessed by medical staff. Prior to 2004, there was 
an awareness of the presence of psychological distress (van’t Spijker, Trijsburg & 
Duivenvoorden, 1997), however, interventions for emotional distress were largely seen as the 
work of clinical psychologists (Rieger, Touyz & Wain, 1998). 
 
iii) Mental Health and Cancer 
 
Whilst the NICE guidelines (2004) have influenced researchers and clinicians to consider the 
psychological impact of cancer, there has been little acknowledgment for those with 
psychological health needs preceding their cancer diagnosis. 
 
Research suggest that as much as 50% of people with cancer have experienced a mental 
health condition in their lifetime and for approximately 30% of cancer patients these mental 
health conditions have been chronic (Derogatis et al., 1983; Massie, 2004; Akechi et al., 
2004;  Walker et al., 2012; Krebber et al., 2014; Watts, Prescott, Mason, McLeod & Lewith, 
2015; Walker, McGee & Druss, 2015). Individuals with severe mental illness are found to 
smoke more than the general population (Kelly & McCreadie, 1999), engage in less physical 
activity (Daumit et al., 2005), have less healthy eating habits (Scott & Happell, 2011) and 
take medications that have side effects related to cancer (Correll, Detraux, De Lepeleire & De 
Hert, 2015). Each of these factors can increase someone’s vulnerability to cancer. 
 
iv) Current Review 
 
Despite the understanding that factors associated mental health can be associated with cancer 
risk factors and that having cancer can lead to adverse psychological experiences there is 
little understanding of the relationship between cancer care and pre-existing mental illness. In 
their position paper, Howard et al., (2010) proposed the presence of disparities in the use of 
screening services, receipt of specialist treatments and mortality rates, for people living with 
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pre-existing mental illness’. This is fitting with the findings from research into health care 
and cancer (Thornicroft, 2011); including conditions such as cardiac disease (Desai, 
Rosenheck & Druss, 2002) and diabetes (Sullivan, Han, Moore & Kotria, 2006). 
 
The present review seeks to systematically answer the question “What are the challenges of 








i) Identification of Papers 
 
a. Search Strategy 
Electronic searches were conducted on 20th August 2018 using PsychInfo, PsychArticles, 
Embase and Medline. To identify all relevant papers, to the present question, a broad search 
strategy was used. Table 1 presents the search terms and strategy used. The researcher 
identified the terms related to mental health by consulting the Mind website’s list of ‘types of 
mental health problems’. (Mind, N.D; accessed on 17th August 2018).  A further search was 
conducted on 3rd September 2018 using Scopus and CINAHL. The phrase ‘Pre-existing 
mental health cancer’ was searched on these free text databases.  
 











10. Mental health 
11. Mental illness 
12. Mental disorder 
13. Psychiatric patient 
14. Mental issue 
15. Mental difficulties 






21. Body dysmorphic 
disorder 
22. BDD 


























44. Sleep disorder 
45. Suicide* 
46. Psychotic 




(2 or 3 or 4 or 5 or 6 or 7 or 8 or 9) 
AND 
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(10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 
or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 
41 or 42 or 43 or 44 or 45 or 46) 
 
b. Inclusion and Exclusion Criteria  
Table 2 presents the inclusion and exclusion criteria which was used to screen the papers 
produced by the search. 
 
Table 2. Inclusion/exclusion criteria. 
Inclusion/Exclusion criteria 
Included: Study participants who had 
experience and/or a diagnosis of mental 
illness prior to their diagnosis of cancer 
Exclusion: Study participants who 
developed mental illness following their 
diagnosis of cancer 
Included: Empirical studies concerning 
cancer outcomes or experiences; this 
including diagnosis, treatment, mortality, 
survival, reactions to cancer, care packages, 
liaison with health professionals, 
professional issues and challenges 
Exclusion: Empirical studies solely 
concerned with topics such as the 
prevalence of mental illness in cancer and 
vice versa 
Included: Empirical studies published in the 
English language 
Exclusion: Empirical studies that were not 
available in the English language 
Included: Papers that concerned mental 
illnesses defined as a mental illness by the 
Mind (N.D) website 
Excluded: Papers concerned with Dementia 
and Learning Disabilities, two populations 
who are seen within mental health services 
but have an organic aetiology. 
 
c. Database Search Results (PRISMA) 
Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), 
Figure 1 presents the flow of papers and information found through the different phases of 
the review. Using the PRISMA method allows for clarity and transparency of the 
methodological approach (Moher, Liberati, Tetzlaff & Altman, 2009). 
 
A total of twenty-six papers were included in the final review. The search of Ovid databases 
(PsychInfo, PsychArticles, Medline and Embase) yielded a total of 4,908 citations. After the 
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removal of duplicates, 2,477 of titles were screened for eligibility. Of these, 2,421 were 
identified as reviews or irrelevant. Following this the abstracts of the remaining fifty-six 
papers were screened for inclusion/exclusion criteria. Forty-six were excluded on the basis of 
this criteria leaving ten papers. The reference sections of the papers found in the search were 
screened and an additional sixteen papers were identified as appropriate and met the criteria 
for inclusion.  
 
 




Figure 1. PRISMA flow of information through phases of the review 
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ii) Quality Review 
a. Method of Quality Appraisal 
The ‘QualSyst’ tool developed by Kmet, Cook & Lee (2004) provides a scoring systems for 
Quantitative research (See Appendix 1 for scoring guidelines). The QualSyst tools were 
particularly useful for this review as there is not a reliance on papers being randomised 
control-trials but allows for a variety of both quantitative and qualitative methodology, which 
was the case with the papers identified. For quantitative papers, quality is defined based on 
the clarity, transparency, the controls for bias and the presence of an appropriate amount of 
information. For the qualitative papers quality was defined broadly by the adherence to a 
defined methodology, transparency and evidence of controlling for biases.  
 
A number of additional quality indicators were included in the rating scale to account for the 
number of epidemiological studies that were included in the review. The Strengthening The 
Reporting of Observational Studies in Epidemiology (STROBE; Von Elm et al., 2007) was 
referred to and a number of the additional items were based on indicators used in this 
measure.  
 
All studies reviewed and included in this paper were quantitative. 
 
b. Quality Scores of reviewed papers 
A summary of the quality ratings for the reviewed studies is presented in Table 3 (please see 
Appendix 1 for guidance on scoring). 
 
The studies reviewed were clear in their descriptions of the study question or objective, those 
which were not clear still identified a gap or inadequacy in the research rather than a defined 
question. Fifteen studies were rated as being flawed in the study design; this was largely due 
to the high number of retrospective case linkage designs. Whilst this allows for a large 
sample size it is flawed due to the potential for bias. A prospective epidemiological design, 
such as the one described by Tran et al. (2008), is an example of a better design. Furthermore, 
ten studies were found to be missing reports of key participant information, such as age. 
 
For all studies both random allocation and blinding were not applicable. This was also the 
case for controlling for confounding in the experimental arms, due to studies not dividing 
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participants into separate conditions. This highlights the absence of any randomised control 
trials or interventional studies in the reviewed literature. 
 
The outcomes for fourteen studies were perceived to be open to improvement. This again was 
largely due to the large number of epidemiological studies which relied on retrospective 
notes. These notes are open to bias and furthermore, some data may be missing, such as data 
that was not required to be kept in medical records. Furthermore, the use of case notes meant 
that the studies were limited in the outcomes they were able to use and thus the studies were 
lacking in their reports of influencing and moderating factors such as socioeconomic status 
and social support. 
 
 However, of the studies reviewed there was consistency in the analytic methods used; most 
studies used regression and or chi-square to analyse the data, those that were concerned with 
mortality and/or survival rates often choose to use a survival curve to analyse the data. 
Results from these analyses were reported in sufficient detail with tables and figures to 
support the written results, all studies reported at least one effect size for the outcome data.  
The studies were found to be accurate in their conclusions, based on the results reported. 
Whilst one would assume due to the large sample sizes in these studies that the results would 
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Provide in the abstract an informative and balanced summary of what was done and what was found 2 2 2 2 2 2 2 2 2 
Question/objective sufficiently described? 2 2 2 2 2 2 2 2 2 
Design evident and appropriate to answer study question? 1 2 1 2 2 1 1 2 1 
Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-
up, and data collection 2 2 2 2 2 2 2 2 2 
For each variable of interest, give sources of data and details of methods of assessment 
(measurement). Describe comparability of assessment methods if there is more than one group 0 2 2 2 2 2 2 2 2 
Method of subject selection or source of information described and appropriate? 2 2 2 2 2 0 2 2 1 
Subject (and comparison, if applicable) described? 1 2 2 0 2 2 0 1 0 
Was random allocation described? N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Blinding described? N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Outcome measures described and robust to misclassification bias? Means of assessment reported? 1 1 2 1 2 1 2 2 1 
Sample size appropriate? 1 1 2 2 2 2 2 2 2 
Analysis described and appropriate? 2 2 2 2 2 2 2 2 2 
Report other analyses done? e.g. analyses of subgroups and interactions, and sensitivity analyses 0 2 2 2 2 2 2 2 2 
Estimate of variance reported for the results? 1 2 2 2 2 0 2 2 2 
Controlled for confounding 0 2 0 2 2 2 2 1 2 
Results reported in sufficient detail 2 2 2 2 2 2 2 2 2 
Conclusions supported by results 2 2 2 2 2 2 1 2 2 
Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of 
analyses, results from similar studies, and other relevant evidence 2 2 2 2 2 2 2 2 2 
Discuss the generalisability (external validity) of the study results 0 2 2 2 0 1 0 2 2 
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iii) Overview of Studies 
a. Methodological designs 
Twelve papers are cohort epidemiological papers (for a summary of all papers please see 
Appendix 2). These epidemiological papers are correlational, in addition to another thirteen 
studies which are also correlational. These papers focus on the frequency of cancer mortality 
in participants with a mental illness (N=13), receiving cancer treatment (N=10) or screening 
(N=4) and issues around diagnosis (N=6).  
 
b. Participant Samples 
 
A total of 3,735,576 participants were included in this review, although it is difficult to 
ascertain if some participants were duplicated across studies, due to the use of national 
databases. Of these 125,851 are reported as experiencing comorbid mental illness and cancer. 
The remaining participants were either used as a comparison or it was unclear what 
percentage of the sample were participants with a pre-existing mental illness or control. 
 
Participants were recruited via national databases in twelve studies . These being databases 
for various states in the USA, Europe and Eastern Asia. Fifteen studies recruited directly 
from healthcare settings. 
 
Mental Health diagnosis 
 
Mental Health was operationalised in a number of different ways. The majority (N=17) 
through the identification of a diagnostic code (ICD 9/10, N=13; DSM-IV, N=5) in 
participants medical or health insurance records, nine studies reported contact with 
psychiatric services as evidence of a mental illness, Six studies reported the use of diagnostic 
assessments to determine the presence of a mental illness. These diagnostic assessments 
included the Anxiety Disorders Interview Schedule-IV( Grisham, Brown& Campbell, 2005), 
Hamilton Rating Scale for Depression (Hamilton, 1960), General Health Questionnaire 
(version 12; Goldberg & Blackwell, 1970), Hospital Anxiety and Depression Scale (Zigmond 
& Snaith, 1983), Brief Psychiatric Rating Scale (Overall & Gorham, 1962), Positive and 
 
 17  
Negative Syndrome Scale (Kay, Fiszbein & Opler, 1987), Centre for Epidemiologic Studies 
Depression Scale (Devins, 1985), Fresno-Composite Interventional Diagnostic Interview 
(Aguilar-Gaxiola, Vega, Peifer & Gray, 1995) and the Vrangenlijst Voor Kenmerken Van de 
Persoonlikheid(Duijsens, Eurelings-Bontekoe, Diekstra & Ouwersloot, 1993). 
 
Twelve of the studies reviewed focused on all types of mental health difficulties or did not 
specify a target diagnosis. Nine studies specifically cited schizophrenia as a diagnosis of 
interest, while seven focused on individuals with a diagnosis of depression. In addition to 
this, three studies specifically named people living with diagnoses of bipolar, anxiety or 
personality disorder as being of interest. 
 
Type of cancer 
 
The most common cancer focused upon in the studies reviewed was breast cancer (N=11). In 
addition to this colorectal, bladder, brain cancer, cervical, head and neck, urethral, prostate 
were studied. Eleven did not specify a specific cancer as the focus of the research. Four 
studies (Alderete, 2006; Xiong, 2008; Tilbrook, 2010 & Laser et al., 2003) studied the use of 
screening services by individuals living with a mental illness, thus these participants at the 
time of the research did not have a diagnosed cancer. 
 
Cancer was operationalised in eighteen of the studies reported by registration on a cancer 
registry or in patients files, with a corresponding ICD code. Nine studies conceptualised 




Thirteen of the studies reviewed did not report the age range of inclusion for participation; 
however, most provided a mean age of those who were included in the studies. Three studies 
targeted participants who may be referred to as older adults (67+) and a total of 7 studies 
reported targeting individuals of working age and older, although it was inconsistent at what 
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The studies reviewed included both male and female participants; Eighteen studies combined 
research of both genders. Nine studies reported findings from only one gender; seven of these 
studied the experience of females with breast cancer or being investigated for breast cancer, 
via a mammography (Lam et al.,2017; Alderete et al., 2006; Iglay et al., 2017; Goodwin et 
al., 2004; Sharma et al.,2010; Ribe et al., 2016; Carney et al., 2005; Xiong et al., 2008). A 
further study focused on females receiving cervical cancer screening (Tillbrook et al., 2010) 
and one study focused on males (Batty et al., 2016). 
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3. Findings 
 
What are the challenges of providing cancer care to individuals with a pre-
existing mental illness? 
 
 
The present literature found that the challenges of providing cancer care to individuals with a 
mental illness were providing a timely diagnosis, offering and making accessible the 
recommended treatment and the increased vulnerability to mortality as a consequence of 
cancer. These findings pertaining to these three factors will be described. 
 
i) Providing a timely diagnosis 
 
When reviewing Medicare surveillance, epidemiology and end results (SEER) data 
Baillargean et al., (2011) found that older adults(67 years and older) living with mental 
illness, for at least 2 years prior to their cancer diagnosis, were more likely to either be 
diagnosed at an unknown stage of cancer (with a lack of stage being recorded in their medical 
notes) or during autopsy, when compared with the normal population. The medical reports of 
fifty-five veterans living with both schizophrenia and breast cancer indicated that these 
patients had ignored signs of breast cancer, such as a palpable breast mass, nipple retractions 
and nipple discharge for anytime between six months to nine years, resulting in diagnoses 
being made when the tumour was categorised as stage III-IV (Hwang et al., 2011) and 
metastases being present (Kiesley et al., 2013). Iglay et al. (2017) & O’Rouke et al., (2008) 
supported these findings, reporting in three thousand six hundred and ninety one & six 
hundred and thirty, respectively, psychiatric patients a delay in excess of 90 days between 
symptom recognition and breast cancer diagnosis, as reported on the patient’s medical 
records. This was in comparison to delays of 35 days in a breast cancer patient without a 
mental illness (O’Rouke et al., 2008). 
 
Shinden et al., (2017) reported that individuals with comorbid mental illness and breast 
cancer were less aware of their cancer symptoms and thus were reliant on family members 
and care staff to identify symptoms warranting investigation. Even when there was evidence 
of screening for cancer (breast, cervical, colorectal & prostate) medical records highlighted 
that individuals with mental illness’ were less likely to return for routine screens, thus 
meaning their screenings were out of date (Xiong et al., 2008). 
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Lasser et al., (2003) found evidence to contradict this and suggested that there was no 
difference in mammography rates between women screened positively for mental health 
difficulties and those who screened negatively for mental health difficulties and Cunningham 
et al., (2015) found that a diagnosis of depression was not associated with a delay in 
diagnosis, although a diagnosis of schizophrenia was. Carney and Jones (2005) reported a 
correlation between the severity of an individual’s mental health difficulty and increasing 
vulnerability for not having received a mammography.  
 
Waidia et al. (2015) also reported no difference between the diagnosis time for veterans with 
or without mental health difficulties. However, the setting for recruitment was unique, being 
a veteran health affairs centre where mental health services were integrated with primary care 
services. They concluded that this offers a good example of how the delay in diagnosis for 
people living with comorbid mental illness and cancer can be overcome. 
 
 
ii) Accessing appropriate treatment 
 
Medical data reviews found that patients with a psychiatric diagnoses were less likely than 
individuals without a psychiatric diagnoses to receive a variety of specialised cancer 
treatments (Kiesley et al., 2013); these included surgery for patients with oesophageal cancer 
(O’Rouke et al., 2008) and colon cancer (Baillargeon et al., 2011), adjuvant chemotherapy 
(Baillargeon et al.,2011; Hwang et al., 2011; Iglay et al., 2017; Shinden et al., 2017), 
radiotherapy (Bailargeon et al., 2011; Shinden et al., 2017)  and postoperative endocrine 
(Hwang et al., 2011). In those that were offered treatment, Goodwin et al., (2004) found in 
1,841 patients records, who were diagnosed with depression (present for at least two years) 
and breast cancer, that these patients were more likely to be offered inappropriate treatment, 
when compared to breast cancer patients without a diagnosed mental illness. Furthermore, 
Shinden et al. (2017) found that in forty-six patients diagnosed with schizophrenia, dementia 
or intellectual disabilities, more total mastectomies were used to treat breast cancer than in 
those without such a diagnosis. 
 
The absence of psychiatric information (name of psychiatrist and antipsychotic medication) 
in patients notes and/or inpatient psychiatric admission, for people with a comorbid mental 
 
 21  
illness was correlated with disruptions to cancer treatment (Irwin et al., 2017), as was a poor 
understanding of the treatment and the presence of negative symptoms (in the context of 
schizophrenia; Inagaki et al., 2006). 
 
In contrast to this, Ganzini (2010) found that for sixty veterans living with schizophrenia and 
cancer, their end of life care was either comparable or better than those without a 
schizophrenia diagnosis. End of life care included being enrolled in a hospice, having an 
advanced directive, having orders relating to CPR and tube feeding, orders from physicians 
regarding life sustaining treatment, place of death, being prescribed opiates, and having a 
cancer biopsy, chemotherapy and surgical treatment for cancer. Waidia et al. (2015) also 
reported that veterans with mental illness did not appear to have different treatments to those 
without a mental illness. 
 
iii) Increased incidence of death due to cancer 
 
The literature (N=9) that focuses on patient mortality reported that having a pre-existing 
mental illness increases a person’s risk of dying from their cancer, relative to the general 
population (Goodwin et al., 2004; Kiesley et al., 2008; Tran et al., 2008; Gathinji et al., 2009; 
Batty et al., 2012; Guan et al., 2013; Musuuza et al., 2013; Cunningham et al., 2015; Ribe et 
al., 2016) 
 
Kiseley et al., (2008) collated mental health records and cancer registrations along with 
records of death. The researchers found an increase in cancer mortality, which they 
concluded could not be explained by an increase in cancer incidence, as they had found that 
to the contrary individuals with a mental illness had a decreased incidence of cancer, relative 
to the general population. More so it was that the risk of death for cancer patients with a pre-
existing mental health diagnosis, was higher than the risk that would be expected for just 
cancer (Stommel et al., 2001); even when accounting for degree of disability, tumour grade 
and treatment modalities the risk for patients with a mental illness was still markedly 
increased (Gathanji et al., 2009). 
 
Guan and colleagues (2012) found that in the time following cancer diagnosis, patients with a 
mental illness (schizophrenia, bipolar and depression) were more likely to die by suicide or 
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other causes than matched controls without a mental illness . In addition to this, those with 
pre-existing mental illness who survived the increased vulnerability of death by suicide or 
other causes were then at an increased risk of dying due to their cancer. Stommel, Given and 
Given (2001) found that the risk of mortality for patients with pre-existing depression was as 
great as the risk for individuals with pre-existing physical difficulties. 
 
Explanations for the excess mortality in cancer patients was attributed to the aforementioned 
factors of disparities in treatment and delays in diagnosis (Jackson et al., 2013; Cunningham 
et al., 2015) patients with mental illness were reported to die more frequently within a year of 
their cancer registration (Batty et al., 2012) and for some the diagnosis of cancer was only 
made during autopsy (Baillargeon et al., 2011). Cunningham et al., (2015) reported that the 
high burden of physical illness and co-morbidities in cancer patients could explain some of 
the increases in mortality found. 
 
Of all mental health difficulties studied, Baillargeon and colleagues (2011) reported that 
individuals living with schizophrenia and dementia were at the greatest risk of mortality due 
to their cancer diagnosis. 
  
 




The present review provides a view into cancer care for individuals with a comorbid mental 
illness. The literature suggested that the majority of people with a mental illness are less 
likely than the general population to attend screening services for cancer, which may delay 
diagnosis and contribute to the excess in case fatalities. Furthermore, the recommended 
treatments for several cancers were found to not be offered to patients with a mental illness 
and, if offered, were difficult to carry out. It appeared that there was a positive correlation 
between disparities in cancer care and severe mental illness. However, exceptions to these 
findings were found in patients treated in veteran health care settings, where physical and 
mental health are addressed within the same service. 
 
What are the challenges of providing cancer care for individuals with? 
 
The studies reviewed here largely provide an observation of the correlation between mental 
illness and disparities in cancer care. This is fitting with the findings that disparities exist in 
other physical illness’ (Desai, Rosenheck & Druss, 2002; Sullivan, Han, Moore & Kotria, 
2006). However, only few of the studies included in this review attempt to provide an 





Table 4. A table summarising the reported reasons for disparity in the care of people with comorbid mental illness and cancer. 
Study Disparity in Reported Reasoning 




































• Patients with negative symptoms, of schizophrenia, find it hard to understand and co-operate 
with treatment 
• The disease is advanced and is no longer amenable to first line treatment 
• Clinicians were unable to give sufficient notice of cancer to patients who went untreated 
 




• Presence of COPD or infection 
• Patient Declined 
• Patient with “Schizophrenia symptoms” 
• Disorientation from a lobotomy (earlier in life) 
 
• Treatment not offered by clinician 
• Treatment refused by patient 
• Hostility towards carers 
• Advanced stage cancer at diagnosis 
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Kiesley et al., 2013 
 
 
Cunningham et al., 
2015 
 















• Diagnosed later 
• Less likely to have had surgery, chemotherapy or radiotherapy 
• Less likely to have had chemotherapy at stage 3 
 
• Metastasis more likely to be found at diagnosis  
• Less specialist treatment 
 
• Later stage at diagnosis 
 
 
• Not having a documented psychiatrist 
• Not having documented antipsychotic medication 





The absence of screening was found to be both a disparity in itself and a cause for increases 
in mortality (Cunningham et al., 2015). Cancer screening is advised as a preventative strategy 
(Stewart, 2014); the lack of use of screening services and detection of cancer appeared to 
onset a difficult cancer journey. This is surprising given the knowledge that people with 
mental illness are in frequent contact with primary care practitioners (Tilbrook et al., 2010), a 
profession who are fundamental in the early detection of cancer symptoms (Department of 
Health, 2000). However, Lam et al. (2016) reported that individuals who screen for high 
persistent distress, often view cancer as “another blow” in life, thus it might be an avoidance 
of “another blow” that leads those with pre-existing mental illness’ to not access screening 
services.  
 
It appeared that a lack of screening leads to delays or lack of diagnosis and an excess 
mortality. 
 
Differences in treatments had a more varied aetiology, being found to be attributable to the 
clinician’s opinion of the patient or the patients expressed preferences. It was found that 
issues such as violence towards staff members (Hwang et al., 2011), difficulty with providing 
consent (Inigaki et al., 2006) or understanding of cancer (Inagaki et al., 2006) were factors 
that clinicians reported as being reasons for not offering treatment such as lung surgery and 
chemotherapy to people with mental illness. Patients were also reported to sometimes refuse 
treatment (Hwang et al., 2011), which often impacted the treatment they received.  
 
Veterans in the USA receive tailored care where both mental health and physical health are 
addressed in the same setting, allowing for better integration of physical and mental health 
(Waidia et al., 2015). However, being a veteran would suggest the presence of a number of 
unique variables, which may have biased the findings of Ganzini et al. (2010) & Waida et al. 
(2015), such as the unique impact of combat on the consequent reactions to distress (Larner 
& Blow, 2011). A randomised control trial would help to understand this further. 
 
ii) Methodological and Conceptual Issues 
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Due to the methodological and conceptual issues that arose whilst conducting this systematic 
review, the conclusions are made tentatively. 
 
The literature available, and thus reviewed, consisted largely (N=22) of data retrieved 
retrospectively from medical reviews, known as a “chart review” (Hess, 2004). This type of 
study is vulnerable to biases created by information being reported inaccurately within 
patient records, as well as only select information being reported or accessible to the 
researchers. Furthermore, the studies reviewed here were unable to control for additional 
confounding variables. Thus, the present data can only suggest a hypothesis that there are 
poor outcomes for people with comorbid mental illness and cancer rather than offering an in 
depth understanding. The use of longitudinal prospective studies, for example where 
participants with comorbid mental illness and cancer are tracked over a number of years, with 
data being recorded for a variety of different outcomes, would be a more robust design, that 
could begin to establish cause and effect. In addition to this, qualitative designs where 
patients and clinicians were asked about their experiences would add depth to this area of 
research. 
 
Whilst searching for the papers reviewed, difficulty was encountered when trying to 
operationalise the search terms. A search of mental health and associated terms alone 
returned a large number of studies, however, the majority of these concerned mental health 
difficulties that occurred after a cancer diagnosis. It is reported that eighty percent of papers 
regarding mental health and cancer are focused on mental health difficulties following cancer 
(Purushotham, Bains, Lewison, Szmukler & Sullivan, 2012). Thus, the search strategy was 
altered to add the term “pre-existing”, however, this was hard to operationalise. This is 
potentially evidenced by sixteen of the studies in this review being found through the 
references section of papers identified in the search. 
 
Furthermore, as a consequence of the difficulty of operationalising the specific target 
population (cancer patients with pre-existing mental health difficulties) and the small amount 
of research into this area (Purusotham et al., 2012), a broad question was asked – not limited 
to any specific part of the cancer journey, experience or a patient demographic. Thus, the 
present findings are vulnerable to bias by a specific demographic. For example, 
schizophrenia was the most frequently researched mental illness, within this study. It is 
understood that individuals living with a diagnosis of schizophrenia are a group exposed to 
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excess mortality, regardless of cancer (Hayes, Marston, Walters, King & Osborn, 2012) with 
some evidence reporting this can result in death fifteen years earlier than the general 
population (Hjorthøj, Stürup, McGrath & Nordentoft, 2017). Furthermore, the present study 
identified that cancer outcomes were worse for people experiencing more severe mental 
health difficulties (Bailargeon et al, 2011; Inagarki et al, 2006) such as psychotic and 
negative symptoms, which are encountered in schizophrenia. 
 
It is understood that mental health does not just affect an individual’s cognitive and 
emotional world, but that there is also a relationship between socioeconomic status (Reiss, 
2013; Carter, Barr & Clarke, 2016), race and ethnicity (Rosenfield, 2012), occupation (Fujino 
et al., 2016) and an array of physical illness’(Scott et al., 2016) . Whilst a few of the studies 
reviewed did consider and control for such as confounding variables, this was infrequently 
done. Thus, the current literature lacks in a holistic understanding of the wider systems that 
may impact or be impacted by a person’s mental illness.  
 
Despite some of the discussed flaws in the methodology and conceptualisation of this study, 
it has still been possible to review and collate the findings of a number of good quality 
epidemiological studies to identify that cancer outcomes are often very poor for patients 
living with mental illness, throughout their cancer journey. These high-power studies and the 
hypotheses that can be generated, provide a good foundation for further research to be 
conducted in this area. 
 
iii) Clinical Implications 
 
A fundamental finding of this study is that the scant use of screening services and detection 
of a cancer has a profound impact on case fatality. However, it is understood that patients 
with mental illness have frequent contact with general practitioners (Tilbrook et al., 2010), 
which offers an opportunity for general practitioners and other clinicians in contact with 
individuals with mental illness to encourage the use of screening services and have 
discussions regarding abnormal bodily symptoms during their contacts with individuals with 
mental illness.  
 
As well as adapting the current physical health checks, this review highlights the need for an 
increase in collaborative working across oncology and mental health settings. In studies 
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where clinicians worked separately there were issues in the clinicians ability to manage the 
mental health symptoms of patients with mental illness (Irwin et al., 2017) and patients’ 
understanding of cancer. It would be expected that clinicians in mental health settings would 
be skilled at sharing difficult information with people with a mental illness as well as using 
strategies to manage challenging behaviour. These skills could be shared with oncology staff, 
in a collaborative working model. Ganzini et al. (2010) presented findings from a service 
where physical and mental health staff worked collaboratively. The findings found that 
veterans with comorbid mental illness and cancer had access to good end of life care, 
including  hospice care and life-sustaining treatment. In the USA this collaborative care for 
veterans is referred to as a whole health care model (Oliver, 2007). In this model both the 
physical and mental health of veterans are offered under the same provider; doing so ensures 
better collaboration between health professionals, leading to better outcomes for people with 
comorbid mental illness and cancer.  
 
iv) Recommendations and Future Research 
 
To further support the claim for a more holistic healthcare model researchers should look at 
conducting randomised control trials comparing the differences in stage at diagnosis and 
mortality rates between individuals cared for in settings that offer a whole health care 
approach with traditional settings where cancer care and mental health care are separate. 
 
Furthermore, to gain a holistic understanding research needs to be conducted where service 
users’ personal experiences are sought. Currently the literature can provide an account of 
cancer outcomes for people living with comorbid mental illness and cancer through the lens 
of the medical reports; thus this is open to biases towards topics that are important to the 
medical field and so is missing a sense of what mental health patients understand to be 
important when living with cancer. This kind of information is key to beginning the path 
towards a co-produced healthcare model, where service users are no longer treated as passive 
consumers of care, but their voices are empowered and services reflect the true needs of 
service users (Realpe & Wallace, 2010). Furthermore, co-production is thought to be an 
influencing factor in supporting self-management in long-term conditions (Wagner, 1998). 
This research highlights that self-management is a potential issue for this population, due to 
the difficulties seen in gaining a diagnosis and understanding treatment. 
 




There is a drive to improve the quality of life of people with a mental illness (Department of 
Health and Social Care, 2014), however, this research highlights how the relationship 
between chronic mental illness and cancer is neglected. We have evidence of the substandard 
outcomes for people with a mental illness once diagnosed with cancer, ultimately leading to 
excess fatalities. Whilst the NICE (2004) guidelines have successfully impacted on 
improvements in the psychological care offered to the cancer population, it appears that 
outcomes for those with pre-existing psychological issues is an area that is still neglected. 
Furthermore, the findings here are similar to that of Howarth et al (2010), further evidencing 
the lack of progress that has been made in almost a decade. 
  
The literature has for over a decade identified that disparities occur from the beginning of the 
cancer journey to the end and now should begin to use cross sectional and longitudinal 
studies to add depth to this finding and look for avenues to improve cancer outcomes in 
patients with mental illness’. Hope is offered by the studies mentioned in the present review 
that report the successful outcomes for patients when oncology services and psychiatric 
services collaborate. In addition to this, research should look to empower the voice of this 
group and their experiences, rather than understand their experience from their medical 
records following their death. 
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Abstract 
 
Introduction: Sarcoma is a rare form of cancer that is often misdiagnosed or diagnosed at an 
advanced stage. Surgery is the recommended first line treatment. Patients diagnosed with 
sarcoma report anxiety before surgery and a percentage of this patient population are at risk 
of psychological distress following surgery. The practice of prehabilitation has a growing 
evidence base for improving surgical outcomes for a range of cancers; however, it is yet to be 
demonstrated if prehabilitation for Sarcoma is feasible and offers benefit to sarcoma patients. 
The present study looks to investigate the feasibility of trialling a randomised control trial of 
psychological prehabilitation for Sarcoma patients. 
 
Method: A controlled pre - post study was designed, following a request from the sarcoma 
health care team at the local trust, reporting a need for care before surgery. Furthermore, 
previous research conducted by Tsimopoulou (2015) and Asfaw (2019), identified the need 
and benefits of prehabilitation in sarcoma patients. A one-hour intervention was created and 
offered to sarcoma patients, recruited to the study. Participants were randomised to either a 
control or experimental arm. Participants were asked to  complete six questionnaires 
regarding their emotional and physical wellbeing. Following this, participants in the 
experimental arm received a psychological intervention with a trainee clinical psychologist 
prior to their surgery. The intervention was informed by Acceptance and Commitment 
Therapy and Compassion Focused Therapy. All participants then underwent surgery. 
Outcome measures were repeated at approximately four weeks after surgery.  In addition to 
the formal outcome measures, the feasibility of the study was assessed in regard to the 
feasibility of recruitment, follow-up and randomisation, amongst other parameters. 
 
Results: Nine participants took part in the feasibility study. It was feasible and acceptable to 
randomise participants between conditions; however, participants completed follow up 
measures within differing timescales. A Cohen’s D power calculation identified that for a 
randomised control trial to have sufficient power, one hundred and sixteen participants would 
need to be recruited. Finally, reliable change calculations highlighted the appropriateness of 
the chosen measures as they were found to be sensitive to changes in this population. 
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Discussion: The study indicated that it would be feasible to implement the psychological 
intervention as part of a  randomised control trial of prehabilitation for sarcoma patients, with 
a number of modifications to the present design. Modifications include embedding the study 
within the service to utilise existing resources in order to increase both recruitment the 
controllability of the study. Furthermore, prehabilitation may only be indicated for a 
percentage of patients with Sarcoma therefore a pathway approach, where individuals are 
screened for vulnerabilities to psychological decline following surgery are identified, with 
other patients receiving treatment as usual.  
  
 





i) Background  Literature 
 
Sarcoma is a rare cancer which can be broadly divided into three types: soft tissue sarcoma, 
bone sarcoma and gastrointestinal stromal sarcoma (Sarcoma UK, N.D). In 2015, 5345 
people in the UK were diagnosed with sarcoma, making up 1.3% of all cancer diagnosed; 
71% of sarcomas diagnosed are of the soft tissue (Sarcoma UK, N.D). Sarcomas will 
frequently be undetected or misdiagnosed (Smith, Johnson, Grimer & Wilson, 2011), 
typically being around 10.2 centimetres by the time they are diagnosed (Sarcoma UK, N.D). 
Once diagnosed treatment is often needed promptly. Surgery is recommended as the primary 
treatment for sarcoma patients (Grimer, Judson, Peake & Seddon, 2010; Gerrand et al., 
2016). Surgery for sarcoma is often palliative in nature and has a poor prognosis (Grimer, 
Mottard & Briggs, 2010);  the tumour can be aggressive and surgery may include limb-
salvage/reconstruction (Shehadeh et al., 2013), amputation (Alamanda, Crosby, Archer, 
Song, Schwartz & Holt, 2012) and the removal of the tumour and its surrounding organs 
(Gronchi, Bonvalot, Le Casne & Casali, 2009). Following on from surgery, patients have a 
higher likelihood of physical disability relative to other cancers (Tang et al., 2012), higher 
levels of pain and a reduction in mobility (Davis, 1999). Thus, the diagnosis and treatment of 
sarcoma offers a unique challenge to patients. Cheville, Beck, Petersen, Marks and Gamble 
(2009) report that often it is not the cancer diagnosis that causes psychological distress for 
patients, but more so the impact of complex treatments, such as surgery. 
 
The period before any surgery is a time of vulnerability for patients due to their physical 
illness but also the psychological issues that occur as a result of anticipating surgery (Ascari 
et al., 2013). Whilst awaiting surgery patients report feeling apprehensive (Vagras, Maia & 
Dantas, 2006), anxious (Fitzsimons, Parahoo, Richardson & Stringer, 2003) and fearful of 
going under anaesthesia (Ruhaiyem et al., 2016). In addition to this, the preoperative phase 
has been characterised by individuals beginning to pre-empt the pain they will experience as 
a result of surgery (Egan, Ready, Neddly & Greer, 1992) and setting unrealistic expectations 
for their recovery (Phil et al, 2016). For cancer patients in particular, Macmillan Cancer Trust 
(2013) reports that the preoperative period involves patients worrying about their cancer 
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growing during the wait or returning after surgery, a decline in self-esteem, financial worries, 
sexual difficulties and difficulties associated with changing life roles.  Potential 
psychological turmoil that patients experience is reported to be elevated in patients awaiting 
major and elective surgeries (Vagras et al., 2006), for which sarcoma surgery would be 
considered one. Research suggests that the experience of these negative states pre-operatively 
has an impact on post-operative outcomes including pain (Granot, Goldstein & Ferber, 2005) 
and wound healing (Broadbent, Petrie, Alley & Booth, 2003). A more complicated recovery 
has been associated with difficulties in the long-term psychological health of patients (Pinto, 
Faiz, Davis, Almourdaris & Vincent, 2016). 
 
NICE (2004) identifies a number of points throughout the cancer journey during which 
psychological intervention may be beneficial, of these, intervention before surgery is 
highlighted. Research too has begun to identify the benefits of intervening between diagnosis 
and surgery (Cheema et al., 2011). The act of intervening during this period has been coined 
‘prehabilitation’ (Silver, Baima & Mayer, 2013, p.307).  
 
Research into the impact of sarcoma is sparse, possibly due to the rareness of the disease and 
range of locations that sarcoma can affect (Fletcher et al., 2002), however, associations have 
been made between sarcomas and the risk of physical, functional and psychosocial 
difficulties (Pakulis. Young & Davis,, 2005 & Aksnes et al., 2009). The majority of the 
research focuses on these risks as a long-term effect of sarcoma rather than exploring the 
wellbeing of patients during the brief but distressing interim between receiving a diagnosis 
and awaiting surgery.  
 
In the interim between diagnosis and treatment of sarcoma, clinical levels of anxiety are 
reported in 29.4% of patients and clinical depression in 22.6% (Paredes et al., 2011). Paredes, 
Pereria, Simoes & Canavarroo (2012) report that sarcoma patients who are particularly 
vulnerable to experiencing psychological distress include those living with partners, people 
who infrequently used humour and those who presented as being in denial of their diagnosis.  
Typically, living with a partner and having a family would be considered a protective factor 
against depression (Inaba, Thoits, & Ueno, 2005), however, it is possible that the impact of 
disability following sarcoma surgery impacts on an individual’s role in their family, thus 
giving rise to feelings of anxiety or depression. Both lack of humour and denial are 
understood as contributors towards psychological distress. The use of humour has been 
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associated with protection from compassion fatigue (Perry, 2008 & Moran, 2013) and so the 
absence of humour may give rise to reduced self-compassion. Self-compassion is positively 
correlated with physical (Dunne, Sheffield & Chilcot, 2016) and emotional (Zessin, 
Dickhauser & Garbade, 2015) wellbeing, while patients who engage in denial are reported to 
be vulnerable to post-traumatic stress responses (Richardson, Morton & Broadbent, 2016). It 
may be of benefit to offer patients presenting with these social and emotional coping 
strategies, with psychological support to prevent subsequent psychological distress. 
 
In a review of current psychological prehabilitation offered before surgery to treat cancer 
Tsimopoulou et al. (2015) reported the following interventions to be in use: relaxation 
techniques (progressive muscular relaxation, breathing and meditation), guided imagery, 
problem solving and coping strategies, psychoeducation regarding the planned surgery and 
psychotherapy. Frequently, psychological prehabilitation interventions are offered for a brief 
period of time, namely, 1-2, one-hour sessions (Larson, Duberstein, Talbot, Caldwell & 
Moynihan, 2000; Haase, Scwenk, Hermann & Muller, 2005; Parker et al., 2009; Cohen et al., 
2011; Garssen et al., 2013). Benefits of psychological prehabilitation include improvements 
in immunologic functioning, quality of life, somatic symptoms, psychological outcomes 
(Tsimopoulou et al., 2015), pain, return to premorbid functioning and discharge from hospital 
(Powell et al., 2016). 
 
Research into prehabilitation is in its infancy and so traditional psychological interventions, 
such as stress management (Parker et al., 2009; Garssen et al., 2008; Cohen et al., 2011) have 
currently been trialled. However, it is possible that new third wave psychological 
interventions such as acceptance and commitment therapy (ACT; Hayes, 2004) and 
compassion focused therapy (CFT; Gilbert, 2009) may be beneficial in addressing the unique 
challenges faced by sarcoma patients.  
 
Acceptance and Commitment Therapy (ACT) is growing in popularity as an intervention in 
physical health settings, with evidence showing it to be an effective intervention for patients 
in chronic pain (Dahl, Wilson & Nilsson, 2004; Wicksell, Ahlqvist, Bring, Melin & Olsson, 
2008; Thorsell et al., 2011; Wetherell et al., 2011; Burham et al, 2013) diabetes (Gregg, 
Callaghan, Hayes, Glen-Lawson, 2007; Amsberg, Livheim, Toft, Johansson & Anderbro, 
2018) and irritable bowel syndrome (Ferreira, Gillanders, Morris & Eugenicos, 2018). ACT 
can be summarised into two principles (a) clarifying individuals values and encouraging an 
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individual to move in the direction of those values and (b) promoting defusion as a way of 
getting an individual to engage in valued behaviours when feared situations are present 
(Guiterrez, Luciano, Rodriguez & Fink 2004). For sarcoma patients this offers a promising 
avenue of prehabilitation due to the acknowledgment that the feared situation is real whilst 
respecting the values that an individual holds and empowering them to move towards these 
goals regardless of the feared situation – without intervention it is possible that upcoming 
surgery and disability following surgery may leave someone with the belief that they cannot 
continue to live in accordance with their values. ACT has proven to be effective in promoting 
hope (Montazer, Nemati, Dehghani & Fallah, 2017), quality of life (Chambers et al., 2015), 
reducing fatigue, improving sleep quality and resilience (Golshani & Pirnia, 2019).  
 
A further third wave therapy may have value. Compassion Focused Therapy (CFT) suggests 
that when an individual’s emotional regulation systems are unbalanced, distress arises 
(Gilbert, 2009). The emotional regulation systems include the Threat System, which is 
concerned with protection; the Drive System, which is concerned with obtaining resources; 
and the Soothing System, which is concerned with managing distress (Gilbert, 2009). 
Compassionate approaches aim to rebalance the system by activating the Soothing System 
through the use of compassion, such that people are better able to cope with distress (Gilbert, 
2009). For sarcoma patients it is likely that the diagnosis of a potentially life-threatening 
condition, which requires surgery, and that could leave one with a range of physical 
impairments would trigger the Threat System and the associated emotions (fear and anxiety) 
and behavioural repertoires (e.g. fight or flight, avoidance). Thus, it is possible that an 
intervention aimed at promoting self-compassion may counteract the emotional distress that 
arises from sarcoma. In support of this hypothesis, Fogarty and colleagues (1999) found that 
even a brief exposure to a compassionate intervention improved psychological wellbeing in 
cancer patients. Furthermore, self-compassion is understood to be a protective factor for 
cancer patients against psychological distress (Pinto-Gouveia et al., 2014). 
 
ii) Aims and Rationale 
 
In order to restore inner balance, under new circumstances and reduce emotional discomfort 
cancer patients need to be able to adjust to their cancer (Religioni, Czerw & Deptala, 2018). 
However, the challenges that arises from sarcoma and surgery, in addition to the brief period 
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of time between diagnosis and surgery make it unlikely that sarcoma patients can engage in 
the cognitive and behavioural process of adjusting to their. 
 
A series of studies, conducted within the current setting, has looked to identify how with 
assistance from psychological knowledge patients could be supported during the period 
between diagnosis of sarcoma and surgery. The first study, a systematic review, looked to 
answer the question the effectiveness of psychological prehabilitation for cancer patient’s 
(Tsimopoulou et al., 2015). The second study looked to understand, through qualitative 
methods, the experience of surgery for sarcoma patients and their perceptions of what would 
have been helpful prior to surgery. The present study looks to investigate how feasible it is to 
study psychological prehabilitation for sarcoma patients before they receive surgery.  
 
 
The present study specifically looks to investigate the feasibility of conducting a Randomised 
Controlled Trial (RCT) in a national centre of cancer excellence, offering soft tissue and 
gastrointestinal stromal tumour sarcoma patients a one-hour psychological prehabilitation 
setting informed by ACT, CFT and pre-existing prehabilitation methods. Arain, Campbell, 
Cooper & Lancaster (2010) defines a feasibility study as one which looks to trial the design 
of the study, focusing on features such as: 
• Standard deviation of the outcome measures, so to allow for estimates of the sample 
size to be made 
• Willingness of participants to be randomised 
• Willingness of clinicians to recruit participants 
• Number of eligible patients 
• Characteristics of the proposed outcome measure 
• Follow-up rates, response rates to questionnaires, adherence/compliance rates 
 
With this in mind, the present study looked to explore the various parameters required for 
successful implementation of an RCT, whilst also exploring the preliminary individual 
differences between participants.  
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Whilst the individual differences of participants was of interest a feasibility study does not 
focus on gaining a large number of participants (Arain et al., 2010). Thus, the present study 








i. Ethical Approval 
 
Ethical approval was sought and approved by the East Midlands Research Ethics Committee 
(see Appendix 3) via the Health Research Authority (see Appendix 4). In addition to this, 
approval was granted by Research and Development from the local teaching hospital trust 
to conduct this research at the local cancer centre of excellence within a large teaching 





The present study was a feasibility study using a randomised control design. The researcher 
sought to test the feasibility with regard to several factors: i) recruiting participants with a 
sarcoma in the time  period after diagnosis and before surgery; ii) the feasibility and 
willingness of participants to be randomised to control and intervention arms iii) the 
acceptability of the  intervention; iv) the sensitivity of the measures to change in this 
population v) any changes seen between pre and post in participants;  v) the follow up rates 
of recruited participants. 
 
Prior to this study a qualitative study was conducted with a sample of Sarcoma patients 
(Asfaw, 2019). This study asked participants what their lived experience of the sarcoma 
surgery was and what people believed would have been beneficial to them before their 
surgery. It was proposed that this study would inform the design of the present study. 
However, there were delays in this study meaning that the protocol was designed before the 
results of the qualitative study had been collected and analysed. 
 
iii. Participant Recruitment 
 
An opportunity sampling strategy was applied; participants were initially approached during 
their clinic appointment where the diagnosis of sarcoma was being investigated. At this 
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appointment participants, who met the eligibility criteria to participate (see Appendix 7), 
were given a verbal introduction to the research by their sarcoma surgeon (see Appendix 7) 
and provided with an information leaflet to consider their participation in the study (see 
Appendix 8). At their next clinic appointment, more than 1 week later, patients were asked if 
they had had chance to consider participating in the research and if they would like to 
participate. Patients who expressed an interest in participating were then advised that the 
researcher for the research would need to contact them, to provide more information and 
instructions relating to their participation, and so they were asked to sign a form consenting 
to being contacted by the researcher (see Appendix 9). 
 
The surgery team then provided the researcher with the potential participants’ names and 
their email address. This information was shared via a secure NHS email or in person when 
their researcher visited the hospital site. 
 
The researcher contacted participants via telephone call. Participants were provided with a 
recap of the study, similar to the introduction that the surgeons had provided. The 
randomisation procedure was explained(See Appendix 10), and the researcher clarified if the 
participant had access to the internet, to enable them to complete the questionnaires and sign 
the online consent form. If participants confirmed they had internet access then they were 
asked for their email address and then sent a consent form (to sign online; See Appendix 11), 
a link to the online questionnaire(see Appendix 12 for questionnaires used) and a unique 
participant code (produced using a random code generator tool). Participants were asked to 
send back their consent form to the researcher’s secure email address.  
 
For participants in the intervention arm, the researcher liaised with the hospital team to 
identify a time and date that was convenient for the participant to receive the psychological 
intervention, before surgery.  Participants in the intervention arm then received the 
psychological intervention, in a clinic room next to the general surgery ward at the teaching 
hospital, in addition to treatment as usual.  Participants in the control arm received only 
treatment as usual. Treatment as usual is defined as clinic appointments to investigate the 
sarcoma, a preoperative assessment and access to a clinical nurse specialist for support. Four 
weeks after surgery, all participants were contacted and asked to complete the post-surgery 
measures (see Appendix 12). In addition to this, the chief investigator kept a reflective diary, 
documenting the experience of running the study (see Appendix 13). 
 




Participants were patients with a diagnosed sarcoma who were scheduled to have this 
sarcoma treated via surgery; with the surgery being performed at a national centre in the local 
teaching hospital. Eligible participants were patients age eighteen and above, diagnosed with 
a sarcoma and undergoing surgery, able to provide informed consent, without a known 
mental health difficulty and with a good comprehension of the English language (see 
Appendix 7 for full inclusion and exclusion criteria). 
 
In total twelve patients were recruited over a 5-month period, between October 1st 2018 and 
March 29th 2019. Eight were allocated to the intervention arm of the intervention.  Of these  
eight, five completed the full protocol. Two participants were unable to receive surgery due 
to poor health, another one opted out of the study before receiving the intervention and 
declined to give a reason. A total of four participants were allocated to the control arm. All 
control participants completed the entirety of the study.  
 
v. Data Collection 
 
Before and after their surgery participants were asked to complete six questionnaires. A large 
number of measures were chosen given the novelty of the research, with their being no 
research to hypothesis what elements of wellbeing were amenable to change following 
surgery, in addition to not having data available (at design) from the qualitative study 
regarding the issues that sarcoma patients found important. Thus, fitting with the remit of a 
feasibility study, the sensitivity of the measures for this population was an interest point. 
 
 The aim of these questionnaires was to gain an understanding of participants’ pain and 
functional status, wellbeing and affective mood in addition to measuring factors hypothesised 
to act as mediators: adaptation to cancer and self-compassion. 
 
Outcome measures 
a. Numeric Pain Rating Scale (NPRS; Hatrick, Kovan & Shapiro, 2003) 
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It is well recognised that persistent and chronic post-surgical pain is a frequently reported 
adverse outcome of surgeries for cancer (Macrae, 2001) and NICE (2004) recommend that 
outcomes for sarcoma care should focus on experiences of pain.  
 
The NRS is an 11-point rating scale where responders are asked to rate the severity of their 
pain on a scale of 0 to 10; with 0 representing “no pain at all” and 10 representing “the worst 
pain imaginable”. The NPRS reports both good reliability (α=0.95; Alghadir, Anwer, Iqbal & 
Ahmed, 2018) and validity(α=0.94; Alghadir et al., 2018). Furthermore, it is reported to be an 
appropriate of measure of pain in cancer (Jensen, 2003) as well as being responsive to 
difference in pain for both genders (Ferreira-Valente, Pais-Ribeiro & Jensen, 2011). 
 
b. Nottingham Extended Activities of Daily Living Scale (NEADL; 
Nouri & Lincoln, 1987) 
 
Activities of daily living are of interest following surgery not only because of the correlation 
with pain (Wildgaard, Ravin, Nikolajsen, Jakobsen, Jensen & Kehlet, 2011) but also due to 
the changes being indicative of the recovery journey; immediately after surgery activities of 
daily living are reported to be at a decreased level but in the long term activities of daily 
living typically increase to levels exceeding those before surgery (Amemiya, et al., 2007). 
 
The NEADL is a 22-item questionnaire that measures participants ability to engage in 
activities of daily living (including household chores, managing money and being mobile). 
Participants rate themselves on a four-point scale of how able they are to perform each task, 
with the ratings ranging from “not at all” to “on your own”. The NEADL is widely used both 
in research and clinical practice as a measure of patient wellbeing. The reliability of the 
measure has been reported as having good reliability(α=0.96) and validity(α=90) in physical 
health patients (Nicholl, Lincoln & Playford, 2002; Harwood & Ebrahim, 2002)  
 
c. Compassionate Engagement & Action Scale (Gilbert et al., 2017) 
 
Self-compassion is reported to be a factor that mediates the experience of pain (Wren et al., 
2012). Neff (2003) found that individuals who demonstrate self-compassion were more likely 
to face life challenges by using positive coping strategies and being able to repair their 
emotional state when necessary.  
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The Compassionate Engagement & Action Scale (CEAS; Gilbert et al., 2017) is made up of 
three scales; self-compassion, compassion to others and compassion from others, this study 
used the self-compassion measure. Participants rate themselves on a scale of 0 (never) to 10 
(always) on their motivation and engagement for self-compassion when distressed (8 
statements) and their coping when distressed (5 statements). Gilbert et al. (2017) report good 
validity(α=0.81) and reliability (α=0.88) for this scale.  
 
d. Mini Mental Adjustment to Cancer scale (Mini MAC; Watson et al., 
2008) 
Mental adjustment to cancer can be described as an individual’s cognitive and behavioural 
reactions to their cancer diagnosis (Grassi et al., 2005). The following five responses have 
been identified: fighting spirit, anxious preoccupation, fatalism, hopelessness-helplessness 
and avoidance. A patients’ emotional coping response has been identified as important to 
physical outcomes in cancer patients (NICE, 2004). 
 
The mini-MAC is a 29-item questionnaire where participants rate themselves on a scale of 1 
to 4 (1 meaning “definitely does not apply to me”, 4 meaning “definitely applies to me”) 
against statements representing the 5 aforementioned responses to cancer. The mini-MAC is 
a widely used measure of coping in cancer and is able to demonstrate good validity(α=0.78-
0.93) and reliability (α= 0.62-0.99) (Pereira & Santos, 2014). 
 
e. Hospital Anxiety and Depression scale (HADS; Zigmond & Snaith, 
1983)  
Low mood and anxiety are understood as being common responses to cancer (Linden, 
Vodermaier, MacKenzie & Greig, 2012). The presence and severity of these affective 
conditions can have an impact on functioning, hospital stay and treatment adherence 
(Hopwood & Stephens, 2000). 
 
The HADS is a 14-item scale that asks respondents to rate themselves seven statements 
concerning behaviours related to the presence of anxiety and seven items related to the 
presence of depression. Responders rate themselves against a set of statements relating to 
how frequently they felt or behaved like this. The HADS has been frequently used in 
populations with cancer and is useful in discriminating the presence of these affective 
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conditions from the symptoms of physical conditions (Bjelland, Dahl & Tangen Haug & 
Neckelmann, 2002). Bjelland et al (2002) reported good validity and reliability to the scale. 
 
f. Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; Tennant et 
al., 2007) 
NICE (2004) recognise the need to address the emotional health of cancer patients and 
incorporate this into the care of cancer patients. 
 
The Warwick Edinburgh Mental Wellbeing Scale is a 14-item scale measuring respondents 
experiences of positive mental wellbeing; it is notable for its focus on positive experiences. 
Respondents are asked to rate themselves on a five-point scale of how often they experience 
these attributes of positive mental wellbeing and the scale ranges from 1(none of the time) to 
5 (all of the time). Tenant et al. (2007)  reported that the scale had good content validity, 
good test-retest reliability and was highly correlated with other measures of mental wellbeing 
and had low correlation with measures of general health. 
 
vi. Design of the Intervention 
 
The initial need for an intervention was proposed by surgeons specialising in sarcoma at the 
teaching hospital; they identified the need for the psychological wellbeing of their patients to 
be addressed. Tsimopoulou et al. (2015) had previously, as part of their work with the same 
sarcoma surgery team, conducted a review of psychological rehabilitation before surgery, 
where seven RCTs of psychological interventions before surgery for cancer were identified, 
which found that prehabilitation did result in improvements in well-being, however, the 
literature base was still identified as in its infancy. With this in mind, further work that was 
specific to sarcoma was needed before psychological prehabilitation could be introduced in 
this setting for sarcoma patients.  An exploratory study was conducted by Asfaw (2019) to 
describe the experience of sarcoma patients who had undergone surgery and explore what 
support thought they would have benefited from before. It was identified that patients thought 
a peer-support system to reduce anxiety and more information regarding the risks of surgery. 
Furthermore, existing studies of prehabilitation in non-cancer populations undergoing surgery 
have reported the use of psychoeducation, relaxation, guided imagery, exercise, supportive 
telephone calls and hypnotic interventions (Arthur, Daniels, McKelvie, Hirsh & Rush, 2000; 
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Nelson et al., 2013). As such, the intervention offered was a combination of psychoeducation, 
applied relaxation and  therapeutic techniques/interventions informed by acceptance and 




The literature regarding prehabilitation frequently reports that psychoeducation, including 
information on surgery, its side effects and recovery following it,  is frequently used as a 
prehabilitation intervention for cancer and non-cancer patients (Nelson et al., 2013; Paich et 
al., 2016) to good effect. In particular the results report that psychoeducation provides 
patients with an opportunity to form a realistic expectation of their recovery journey (Arthur 
et al., 2000; Paich et al., 2016). 
 
b. Applied Relaxation 
The use of applied relaxation techniques for physical health conditions has been incorporated 
into practice for a number of decades (Baum & Posluszny, 2000). It has been reported that 
the use of applied relaxation is beneficial in alleviating the effects of cancer treatment and 
also in recovery following surgery (Astin, Shapiro, Eisenberg & Forys, 2002). Parker et al. 
(2009) suggested that that stress management (mainly relaxation techniques guided by a 
psychologist) were effective in improving short- and long-term surgery outcomes, 
particularly regarding physical health. Progressive muscular relaxation, in particular, is 
widely used in health settings (Li et al., 2015) and is evidenced as being an effective 
intervention for cancer patients (Matovina, Birkeland, Zick & Shuman, 2017; Paras-Bravo et 
al., 2018). 
 
c. Acceptance and Commitment Therapy (ACT; Hayes, 2004) 
ACT is a popular psychological intervention in physical health settings and there is a growing 
evidence base for its use for a range of issues, including coping with cancer (Jiménez , 2012). 
An ACT intervention can be summarised into two principles (a) clarifying an individuals’ 
values and encouraging an individual to move in the direction of those values and (b) 
promoting defusion from distress as a way of getting an individual to engage in valued 
behaviours when feared situations are present (Guiterrez et al., 2004). 
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Research has found that the concept of psychological flexibility targets the avoidance of 
negative feelings or thoughts which has been an issue in cancer patients, which in turn 
increased quality of life, experience of distress and mood issues (Feros, Lane, Ciarrochi & 
Blackledge, 2013).  
 
d. Compassion Focused Therapy (CFT) 
It has been found that compassion is a mediating factor between cancer related symptoms and 
psychological distress, with those who reported lower levels of compassion having greater 
emotional difficulties related to their cancer (Przezdziecki et al., 2013). The importance of 
self-compassion as a protective factor, specific to cancer, was highlighted by Pinto-Gouveia 
and colleagues (2014) who found stronger correlations between self-compassion and reduced 
psychological distress when compared to a healthy sample. Even brief exposures to 
compassionate interventions have proved to be effective for cancer patient’s psychological 
wellbeing (Fogarty, Curbow, Wingard, McDonnell & Somerfield, 1999). 
 
The Use of CFT in cancer populations is yet to be fully understood, however, one may 




The procedure for the intervention was as follows: 
1. Participants were provided with a guided tour around the key areas that they would 
encounter during their stay for the visit. This included a tour of the intensive care unit 
and the general surgery ward. For participants unable to do the tour, due to mobility 
or access to wards a verbal description was provided of the wards. 
2. Participant were provided with a space to explore their feelings, thoughts, fears and 
hopes of both their journey so far, surgery and their upcoming recovery. Within this 
conversation the concepts of ACT & CFT were introduced and discussed in the 
context of the conversation. 
3. Participants engaged in an ACT activity where they were encouraged to think about 
their values and how they could continue to work towards these values despite the 
difficulties that may arise during their recovery (see Appendix 14) 
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4. Participants were introduced to the “takeaway documents”(see Appendix 15). In 
particular, participants were given a gift box, and following this the psychologist 
provided instructions on building a box containing compassionate self-help tools.  
5. To end the session, participants were invited to engage in a progressive muscular 
relaxation exercise (see Appendix 16). This lasted for 10 minutes. 
 
viii. Data Analysis 
The data analysis for this study looked to identify whether the study was feasible to conduct. 
The guidance of outcomes of interest as presented by Arain et al. (2010) was divided into two 
categories: feasibility of the process and feasibility of offering the content. 
 
To answer the question of the feasibility of the process, observations were made of the 
descriptive statistics, the participants’ flow through the study and interpretation of the 
researchers reflective diary was made. Furthermore, sample size was estimated by calculating 
Cohens d coefficient. To do so, the mean and standard deviation of the post-surgery outcome 
for both treatment arms on the scale of wellbeing was used. 
 
A reliable change index analysis was conducted to analyse the preliminary individuals 
outcomes. Jacobson and Traux (1991) proposed that using the normative standard deviation 
and test-retest score a reliable change index (RCI) can be calculated to understand the change 
at an individual level. For this study the test-retest reliability was drawn from the existing 
literature and the standard deviation was derived from this samples pre-surgery scores. 
  
 




i. Descriptive Statistics 
Twelve patients consented to participate in the study. Two of these participants were unable 
to undergo surgery, due to illness and so were not followed up. Another one participant 
changed their mind before receiving the psychological intervention, and so was also not 
followed up. For characteristics of the participants who completed the study please see Table 
6. 
 






















































a. Pain and Functional Outcomes 
Table 7 presents that pain and functioning at baseline for both the participants in the control 
(M=3.25, SD=0.82) and treatment (M=3, SD=4.12) report mild levels of pain (Boonstra et 
al., 2016), as shown in table 2. Following surgery, the intervention groups mean (M=3.4, 
SD=2.19) remained in the mild range, whereas the control groups mean (M= 5.5, SD=1.29) 
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rose to a level that would be deemed moderate (Boonstra et al., 2016). Functioning was 
observed to reduce between baseline and post intervention for both participants in the control 
and intervention arms of the study. 
 
b. Affective Mood and Wellbeing Outcomes 
Anxiety prior to surgery and intervention (if allocated to the treatment arm) was found to be 
in the range of clinical concern as described by Zigmond and Snaith (1984) for both the 
control arm (M= 8.25, SD=4.57) and intervention arm (M=9.8, SD=4.44). Depression prior 
to surgery and intervention fell within the “normal” range (Zigmond & Snaith, 1984;) as did 
wellbeing (Stewart-Brown, 2008). Following surgery anxiety decreased in both arms of the 
study, for the treatment arm the new mean would be classified as “normal” (M=6.2, 
SD=3.56). Whilst anxiety reduced in the control arm following surgery, the mean score 
would still be in the range of clinical concern (M=8, SD=3.46). Wellbeing was found to 
decrease in those in the control arm following surgery but increase in participants in the 
intervention arm. Consistent with this depression increased in the control arm to a “borderline 
abnormal” range (M=7.25, SD=2.06) and decreased in the intervention arm. 
 
c. Mediating Factors  
Whilst pain, functioning, wellbeing and affective mood symptoms are the primary outcome 
measures, the study looked to observe the change in potential mediating mechanisms of 
coping (Mini-MAC) and compassion (CEAS) to gain a better understanding of how the 
intervention influenced change, if at all. Prior to surgery participants appeared to engage in 
anxious preoccupation as their primary coping method. Both the control group  and the 
intervention group reported high levels of compassionate engagement(Control M= 32, 
SD=6.78; Intervention M=25.8, SD=11.69) and action(Control M=40, SD=10.03, 
Intervention M=39, SD=18.76) prior to surgery. Following surgery, both groups of 
participants reduced in their use of anxious preoccupation (Control M=16, SD=5.29; 
Intervention M=21.75 , SD=2.06) as an adaptation method and helplessness hopelessness. 
Similarly, both groups of participants reduced in their reports of compassionate action 
(Control M=40, SD=10.03; Intervention M=39, SD=18.76). However, both groups increased 
in their reports of compassionate engagement (Control M=41.6, SD=16.99; Intervention 
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Table 6. Descriptive Statistics of participants scores both pre and post-surgery 










Numeric pain rating scale Intervention 3 (4.12) 3.4 (2.19) -0.4 
 Control 3.25 (0.82) 5.5 (1.29) -2.25 
Warwick-Edinburgh 




















 Control 19.5(3.32)  14(4.08) 5.5 
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 Control 8.25(4.57) 8(3.46) 0.25 











 Control 5(1.41) 7.25(2.06) -2.25 
 






















 Control 24.25(3.95) 21.75(2.06) 2.5 
 

























     
Mini-Mac (Fatalism) Intervention 12.2(1.92) 14.6(2.07) -2.4 
 Control 16.25(1.89) 15(2.71) 1.25 
 









 Control 32(6.78) 35(7.96) -3 
 









 Control  40(10.03) 26.75(4.99) 13.25 
Note * NEADL- Nottingham Extended Activities of Daily Leisure Scale; **Mini-Mental 
Adjustment to Cancer Scale;***Compassionate Engagement and Action Scale. 
 
i. Participant Journey 
 
In the 5-month period that recruitment ran, a total of thirty-two patients consented to be 
contacted by the researcher after having been given introductory information about the 
research. Figure 2 offers an illustration of their journey through the study. Following a 
conversation with the researcher, which included an email with details on how to provide 
informed consent and a link to the questionnaire, twelve participants returned informed 
consent forms and completed the pre-surgery questionnaires. Participants were randomly 
allocated (see Appendix 10 for randomisation procedure). A total of three participants 
dropped out before receiving their surgery, due to poor health meaning they were unable to 
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undergo surgery (N=2) or “changed mind) (N=1). The remaining 9 participants completed 
the entirety of the protocol. At follow up four participants completed the questionnaires 
within the four-week period, the longest wait for follow-up data was eight weeks. Five 




Figure 2. Diagram of the flow of participants through the study  
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i. Sample Estimates 
An a posteriori power calculation was performed to inform the number of participants that 
would be required in a randomised control trial to yield an effect size of .80 at the 95% 
confidence interval. To conduct this power calculation the mean and standard deviation from 
both the intervention (M=52.8, SD=10.18) and control group (M=43.25, SD=5.91), post-
surgery, measures of wellbeing (WEMWBS) was used. Wellbeing was chosen as the primary 
outcome due to the well-researched ability of psychological interventions to influence 
emotional wellbeing in cancer patients. 
 
The Cohens d criterion (D=1.15) posits that to yield an effect size of 0.8 a total of fifty-eight 
participants would be needed in each condition, one hundred and sixteen participants in total. 
 
ii. Reliable change analysis  
The proportion of participants who were classified as showing considerable change (decline 
or increase) or no change are described below for each of the four primary outcome 
measures; pain, functioning, wellbeing and affect (to see individual reliable change scores 




As can be seen in Figure 3, a total of three control participants and two experimental 
participants reported an increase in pain that was reliably and clinically significant at the 95% 
CI (1.80). A further one control participant shows a clinically reliable change (66% CI 
=0.92). By contrast two participants in the experimental arm reported decrease in pain 
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Figure 3. Scatter plot depicting the reliable change index for self-reports of pain, with a line 
of no effect, 66th confidence interval and 95th confidence interval. 
 
 
Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents  clinically reliable change and the green line represents the 95% confidence 
interval and thus scores that are clinically and significantly reliable. 
 




Figure 4 depicts that six participants reported a decrease in functional mobility following 
surgery. Three participants allocated to the control arm and one allocated to the experimental 
arm reported a clinically and reliably significant reduction in mobility (95% CI =2.96). An 
additional one participant in the experimental arm reported a clinically reliable reduction in 
mobility following surgery (66% CI=1.51). Only one participant, allocated to the control arm, 
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Figure 4. Scatter plot depicting the reliable and clinical change reported between pre-surgery 
and post-surgery on the rating of mobility, with a line of no effect and the bandwidths for the 
66h and 95th confidence interval. 
 
 
Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents  clinically reliable change and the green line represents the 95% confidence 




Following surgery, two participants in the experimental arm and one in the intervention arm 
reported both clinically and significantly reliable decreases (95% CI=1.47), as can be seen in 
Figure 5. A further one participant reports a change that would be understood as clinically 







 72  
Figure 5. A scatterplot of the change scores between pre-surgery and post-surgery, for self-




Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents  clinically reliable change and the green line represents the 95% confidence 




As is observed in Figure 6, all participants in the intervention arm reported a decrease in their 
abilities to engage in domestic abilities. Three of these results can be deemed both clinically 
and significantly reliable (95% CI=5.07), two participants in the experimental arm also 
reported a clinically and significantly reliable change too. One control participant and one 
experimental participant report a clinically reliable reduction (66% CI=2.59). Figure 5 also 
depicts that one participant in the intervention arm reported a clinically reliable increase in 
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Figure 6. A scatterplot of the change scores between pre-surgery and post-surgery, for self-




Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents  clinically reliable change and the green line represents the 95% confidence 




All but one participant reported a decrease in leisure activities following surgery, six of these 
decreases are clinically reliable changes (66% CI =2.62). One experimental arm participant 
reported an increase in abilities, however, this was not reliably or clinically significant either, 
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Figure 7. A scatterplot of the change scores between pre-surgery and post-surgery, for self-




Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents  clinically reliable change and the green line represents the 95% confidence 




In Figure 8 it can be seen that all four control participants show a decrease in wellbeing 
following surgery, two of these decrease in wellbeing are clinically and significantly reliable 
(95% CI=8.46) and the additional two participants reported decreases are clinically reliable 
(66% CI= 4.31). Participants in the experimental arm, reported increases, with one of these 
increases being clinically and significantly reliable (95% CI = 8.46) and a further one being 
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Figure 8. A scatterplot of the change scores between pre-surgery and post-surgery, for self-




Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents clinically reliable change and the green line represents the 95% confidence 




Anxiety was reported decrease to a clinically reliable level following surgery for two 
experimental participants and one control participants (66% CI=2.23). Furthermore, one 
participant in the experimental arm reported a clinically and significantly reliable (95% CI = 
4.37) reduction in anxiety following surgery. As can be seen in Figure 9, two experimental 
participants reported increases in anxiety following surgery, these changes were analysed as 
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Figure 9. A scatterplot of the change scores between pre-surgery and post-surgery, for self-




Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents clinically reliable change and the green line represents the 95% confidence 
interval and thus scores that are clinically and significantly reliable. 
 
As can be seen in Figure 10, four out of five participants in the experimental arm reported a 
reduction in depression following surgery; this reduction was clinically reliable (66% 
CI=1.87). Furthermore, figure 10 demonstrates that two participants in the control condition 
reported a clinical and significant reliable increase in symptoms of depression following 
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Figure 10. A scatterplot of the change scores between pre-surgery and post-surgery, for self-
rated symptoms of depression, with a line of no effect and the bandwidths for the 66th and 
95th confidence interval. 
 
 
Note. Black line represents the line of no effect, the red line is the 66% confidence interval 
and represents  clinically reliable change and the green line represents the 95% confidence 
interval and thus scores that are clinically and significantly reliable. 
 
i. Subjective Experience of trialling the research 
 
It was noted during the course of research that reassuring participants that the research would 
not involve extra travel seemed to be important to them (see reflective diary Entry 1 in 
Appendix 13). Therefore, scheduling a time to meet them around their existing appointments 
was key, and flexibility on the part of the researcher supported the implementation of this 
(e.g. meeting participants at the hospital after late appointments outside of normal working 
hours). 
 
The researcher observed that a frequent naturally-occurring process prior to surgery was the 
act of saying goodbye to family members; this was perceived to be an important moment but 
was often interrupted by the psychological intervention (See reflective diary Entry 2 in 
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Appendix 13). Consequently, the researcher reflected on how the intervention ran the risk of 
disrupting an important process of preparing for surgery. 
 
Following surgery, participants reported that the transition home following surgery was 
another difficult time period (see reflective diary entry 3 in Appendix 13). Participants 
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4. Discussion 
 
The present study aimed to investigate the feasibility of running a randomised controlled trial 
in a UK centre of excellence for cancer, where one psychological intervention session was 
trialled before surgery for sarcoma patients. The presence of data to analyse and discuss 
highlights that it is possible to conduct a study of this nature in this setting. However, the 
results of the present study will be discussed regarding the findings of the feasibility of the 
research process and then the feasibility of offering the proposed intervention (the content). 
 
i. Feasibility of the process 
 
Of the participants who choose to participate in the present study generally it was found that 
the study as a whole was acceptable and there were no concerns raised regarding 
randomisation; a number of participants reported being keen to do “anything to help others” 
(see diary entry 4 in Appendix 13). Furthermore, participants completed all the measures 
requested, although at follow-up there were significant delays in the completion of this data, 
thus compromising the feasibility of the follow-up procedure. 
 
Whilst the completion of measures and lack of objection to randomisation is evidence of 
acceptability of the protocol to the minority who participated, the overall recruitment of 
participants was difficult, with an average of 1.8 participants being recruited per month over 
a five-month period. In total 53% of the people who expressed and interest and were able to 
be contacted choose not to participate in the study, after having spoken with the researcher. 
This highlights a potential issue with acceptability for the majority of sarcoma patients 
approached. Inspection of the recruitment process highlights that participants were introduced 
to the research during their clinic appointments with the surgeons. It is hypothesized that 
there may have been a difficulty in processing the research information during the clinic 
appointment, where important and potentially overwhelming health information is already 
being discussed (mainly the likelihood of a cancer diagnosis). Interruptions to the emotional 
and cognitive processing of a cancer diagnosis can have detrimental effects to a participant 
(Oginska-Bulik & Michalska, 2019), effecting a patients wellbeing but also their ability to 
provide informed consent for research. 
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A potential modification to the recruitment strategy would be to establish a role for a research 
assistant embedded in the hospital team, thus allowing the researcher to support the research 
to be introduced at a more appropriate time, rather than during their first clinic appointment. 
This would hopefully lead to an increase in participants. An a posteriori power analysis 
revealed that one hundred and sixteen participants would be needed to provide the study with 
enough power to find an effect, if one was there to be found. If the same recruitment strategy 
was used, where 1.8 participants were recruited per month then it would take five years and 
three months to collect enough participants to conduct the RCT. If modifications to the 
recruitment strategy were made, it would be hoped that participants could be recruited more 
successfully and swiftly. 
 
In addition to an appropriate sample size, an RCT is also expected to measure outcomes at a 
specific time, in order to fulfil the criteria of being controlled (NICE, N.D). In the present 
study this was not fulfilled due to 55% of participants requiring prompts by the clinical nurse 
specialist to complete the follow-up measures such that the four weeks follow up period was 
breached for over half the participants. It is understood that following surgery an individual 
will often temporarily show heightened distress, but this reduces as time passes (White 2001; 
Zabora et al. 2001; Moorey & Greer 2002; Carlson et al. 2004; Paredes et al. 2012). 
Consequently, time is a confounding factor which makes the results difficult to interpret.  
 
Participants did respond to the questionnaires when asked by their clinical nurse specialist 
(CNS). This offers a direction for increasing the controllability of a future RCT. Harding, 
Beesley, Holcombe, Fisher and Salmon (2015) found that breast cancer patients reported that 
the staff member who had supported them the most was their clinical nurse specialist. It is 
hypothesized that this is the reason why the present participants completed the follow-up 
questionnaires for the CNS and thus a collaboration with the CNS team would improve the 
controllability of an RCT. 
 
ii. Feasibility of the content 
 
The measures of pain, functional abilities, wellbeing and affect are shown to be sensitive 
measures of outcome in this sample of sarcoma patients, as indicated by the clinically and 
significantly reliable changes observed in both positive and negative directions. This 
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indicates that each of these primary outcome measures would be appropriate for use in a 
larger scale study, due to their ability to capture scores that reflect change. 
 
Anxiety, for this sample, is established as an issue of concern prior to surgery in both the 
control (M=8.25,SD=4.57) and experimental (M=9.8,SD=4.44) participants. Whilst the 
standard deviations do show a lot of variability, this can be expected in such a small sample 
size and this is a preliminary indication of levels of anxiety that would traditionally be 
defined as “borderline abnormal” (Zigmond & Snaith, 1983). It can be seen that 77% of 
participants reported reduction in anxiety following surgery, three of which can be deemed 
clinically reliable and another one deemed to be reliable both clinically and statistically 
significant. The majority of these changes are seen in the intervention arm, which suggests 
the potential usefulness of contact with a psychologist prior to surgery in addressing a 
primary emotional concern for this population. With a larger sample size, the variability that 
is reported in this study could be explored to identify what levels of anxiety look like prior to 
surgery in this population and how that compares to reports of anxiety that are defined as 
“abnormal”; this could inform the way in which a future study approaches anxiety. 
 
Whilst anxiety bordered levels of clinical concern, wellbeing and depression scores were not 
at such elevated levels. Participants in the experimental condition reported a mean score of 5 
(SD= 1.41) and control participants reported a mean score of 6.4 (SD=4.93) for symptoms of 
depression. According to Zigmond and Snaith’s (1983) classification, these scores would be 
deemed “normal”. Furthermore, participants’ mean scores at baseline (Experimental- 
M=48.4, SD=14.19; Control -M=50.5, SD=10.41),  for wellbeing would be deemed “normal” 
( “Collect, score, analyse and interpret (S)WEMWBS”, N.D). These findings are contrary to 
the high levels of distress that were assumed by the medical team allied to the research. 
 
This finding does not, however, preclude the need for prehabilitation, as prehabilitation does 
not solely focus on high levels of distress prior to treatment but has a focus on difficulties that 
may arise in the future, following treatment, as well as preparing patients for the practicalities 
of surgery (Silver, Baima & Mayer, 2013). We can see the impact that surgery can have on a 
vulnerable minority, in the case of Control Participant 2 (See appendix 17 for individual 
reliable index scores), who at pre-surgery reported relatively robust levels of physical and 
emotional wellbeing, but then reported a number of clinically and statistically significant 
reliable changes, suggesting a detrimental effect. It can be tentatively hypothesized that these 
 
 82  
changes may be attributable to the reliable increase observed in the Mini-Mac scores for 
Helpless-Hopeless and Cognitive Avoidance response to cancer, as well as a decrease in the 
Fighting Spirit and Compassionate Engagement (see Appendix 17 for reliable change index 
scores for the mini-mac). It can be hypothesised that cognitions around ability to cope with 
the realities of recovering from surgery and limited self-compassion could create a cycle 
where distress continues to increase and triggers difficulties in the perception of pain and 
ability to engage in activities. Such a profile may highlight patients who would find 
prehabilitation beneficial. 
 
In the interest of ongoing research and clinical work it may be of value to consider how 
participants’ responses to questions may be more indicative of their coping style rather than 
the dependent variable of the measure. An example of this would be Intervention Participant 
1. This participants’ post-surgery profile appears perplexing. This participant reported 0 pain 
(the same as prior to surgery) and reported no difficulties on any of the activities of daily 
living, which would suggest a good outcome. However, this participant was one of the only 
participants to be observed as having a clinically and reliably significant decrease in 
compassionate engagement (with the other participant being Control Participant 2 who is 
analysed as having experienced a significant decline in wellbeing and did not receive the 
intervention). This outcome on the compassionate engagement scale is contrary to the aim of 
the intervention, which would not have predicted a decrease in compassionate engagement. 
However, Gilbert et al (2017) explains that compassion requires an individual to be aware of 
their distress and suffering for effective engagement. It is possible that Intervention 
Participant 2’s scores on the pain and NEADL allude to their difficulty in acknowledging 
distress. This finding highlights a potential participant profile of whom this intervention may 
not be useful for, in that engagement in their distress, so to bring about wellbeing, is not a 
method they are motivated to use. 
 
A commonality amongst participants allocated to the intervention and control arms of the 
study was the reduction in abilities to engage in domestic activities: five participants reported 
a clinically and significantly reliable change and a further two reported a clinically reliable 
change. As this was shared by both intervention and control participants it can be assumed 
that this was an area impacted by surgery, particularly given that surgery is understood to 
impact on domestic activities (Mosher et al., 2013; Thomas et al., 2015; Poghosyan, Sheldon, 
Leveille & Cooley, 2015). Thus, a further development of the research may be to adapt the 
 
 83  
intervention so to place a higher focus on working towards the values of home life and 
domestic activities, for which ACT has an evidence base for improving, in the context of pain 
(Yu, Norton & McCracken, 2017). 
 
iii. Limitations of Research 
 
Whilst the study was successful in randomising participants, and participants were observed 
to find the randomisation acceptable, blinding was not attempted in the present study. This 
simply did not seem feasible with a research team made up of one person. However, blinding 
does have potential benefits such as less likelihood of participants having a biased response 
to the intervention, investigators/intervention administers are less likely to transfer their 
inclinations or attitudes to participants and assessors of outcomes are less likely to pay 
attention to outcomes that support their proposed hypothesis (Schulz & Grimes, 2002). It is 
possible that any changes observed in the present study can be attributed to the afore-
mentioned biases. However, whilst this must be conceded as a limitation of the present 
research, it still remains difficult to blind participants in such research in an ethically 
appropriate manner. 
 
A further issue with the control of the present study was that in between the pre and post 
measures participants received surgery as well as the psychological intervention, this makes 
the data unclear to determine what is an effect of surgery or the removal of imminent surgery 
and what is the effect of the intervention. Whilst the control group allows for some 
assumptions to be made, a better way of controlling for this would be to add in an additional 
measurement point, before surgery after the intervention has been received. This would allow 
for changes to be tracked before surgery. It would also help in improving the confidence in 
asserting that the increase’s seen in pain were more so attributable to the process of surgery, 




This aim of the present feasibility study has been to inform the design of a randomised 
control trial. The first of these recommendations would be for a larger study to recruit a 
research assistant, embedded into the clinical team. It is hoped that this would allow the 
research to reach the full recruitment potential, as it is hoped that this research assistant 
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would be able to be available to support clinicians with the introduction of the research and 
would be able to be more flexible to support participants needs, both in the instance of 
introducing the research and offering the intervention. Furthermore, this research assistant 
could look to work alongside the clinical nurse specialists, who have been hypothesized as 
useful resources, to solve the issues with control that the present study faced.  
 
Additionally, the results of the present research highlight that a common difficulty 
experienced following surgery was engagement in domestic activities. A following study 
could look to adapt the intervention to address this need in sarcoma patients. In particular 
activities focusing on psychological flexibility and the acceptance of pain are proven to be 
effective on pain related disability, which may explain the psychological disability in this 
population (Vowles, Witkiewitz, Sowden & Ashworth, 2014). However, any further 
researcher will need to give careful consideration to the addition of further elements to the 
intervention, due to the limited time available to offer the intervention. 
 
Finally, as is seen in the researcher’s reflective diary, three participants reported an interest in 
being visited by the intervention administrator for a “top-up” session before they returned 
home. A randomised control trial could look to employ a repeated measures design where 
measures are collected at baseline, following the prehabilitation intervention, following 
surgery and then following the top-up session, to gain an understanding of what is most 
helpful, whilst providing clarification over the effects of surgery and the effects of the 
interventions. 
 
In addition to recommendations for future research, the present research has identified some 
recommendations for clinical practice. In particular, it is seems that such an intervention 
would be helpful for a small percentage of vulnerable sarcoma patients, however, most 
participants may not need an intensive intervention, like the one used here, but could still 
benefit from an ACT and CFT informed care. Thus, it is proposed that in services such as the 
host of the current research, a screening tool of psychological distress could be used, where 
patients could be allocated to one of two pathways; those demonstrating risk factors for 
decline following surgery could be referred for a psychological session, such as the one 
described in the study. Participants who are not screened as vulnerable could be referred to a 
pathway where they still receive ACT and CFT informed care, so to maintain their wellbeing, 
as was seen in this study, but delivered by the traditional clinical team. 
 
 85  
 
v. Reflections 
Whilst this piece of research proposes the need for a potentially beneficial intervention, it has 
to be acknowledged that even to conduct this feasibility study has been difficult. Largely, the 
difficulties have been in recruiting enough participants. Difficulties in running clinical trials 
with cancer patients have been identified (Mills et al. 2006), with difficulties including that 
research can be inconvenient, the research does not feel appropriate for the cancer or is 
perceived to have no benefits. To my knowledge, in the present study, those who dropped out 
following providing consent, mainly did so due to poor health preventing them from being 
able to undergo surgery. One participant reported that they had “changed my mind” and then 
there were a number of people who expressed an interest but did not return consent forms or 
complete the questionnaires. Researching in an area of rare cancer means that the loss of a 
participant or potential participant was disappointing. However, it has been important to be 
open and aware of this disappointment as a clinician and academic researcher. Taking this 
approach has ensured that the response received by participants who have dropped out or 
declined to participate has still embodied the principles of this intervention which are an 
authentic compassionate and patient-focused approach. It is inevitable in this population that 
the seriousness of the illness and the overwhelming feelings that can ensue around a 
diagnosis of sarcoma will impact on the ability to recruit participants, thus it is important that 
research of this nature is not done in isolation and more so as part of a supportive team; a 
team who can support the researcher through the difficulties of recruitment so to ensure that 
any frustrations are not transferred onto a patients experience of sarcoma care or research 
involvement. Complementary to this, an embedded researcher within the service would mean 
that the support could be reciprocal with the researcher developing good lines of 




A novel piece of piece of research has been presented here, that has not only the potential to 
be adapted into a randomised control trial but also the ability to be beneficial in ensuring the 
wellbeing of patients with this rare cancer. The study fulfilled its aims of investigating 
feasibility and can conclude that a study based on this protocol would be feasible, given a 
number of adaptions. 
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OUTCOMES FOR PATIENTS LIVING WITH A MENTAL ILLNESS 
WHEN DIAGNOSED WITH CANCER 
AND 
THE DEVELOPMENT OF A PSYCHOLOGICAL PREHABILITATION 





This chapter provides an accessible summary of a literature review and 
empirical study carried out by Victoria Caines as part of the qualification of 
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Literature Review: Outcomes for Patients Living with a Mental Illness 




Throughout the cancer journey an individual can experience changes in both their physical 
and mental health. The psychological impacts of cancer can include anxiety (Maddineni, Lau 
& Sangar, 2011; Mitchell et al., 2011; Vehling et al., 2012; Ford, Catt, Chalmers & 
Fallowfield, 2012), depression (Mitchell et al., 2011; Walker et al., 2012; Yang et al., 2013; 
Ford et al., 2012), fear of cancer reoccurrence (Simard & Savard, 2009; Puts, Papoutis, 
Springall & Tourangeau, 2012; Swash, Hulbert-Williams & Bramwell, 2014), post-traumatic 
stress disorder (Koutrouli, Anagnostopoulos & Potamianos, 2012) and regret (Chambers, 
Hyde, Ip, Dunn & Gardiner, 2013). 
 
NICE (2004) onset changes in the oncology care where the psychological wellbeing was the 
responsibility of all clinical staff. Consequently, Bultz & Holland (2006) commented on 
symptoms of anxiety being routinely assessed by nursing staff, along with traditional 
measures of physical health. 
 
It is reported that as many as 50% of cancer patients have experienced a mental health 
condition in their life, with 30% of cancer patients having experienced a chronic mental 
health condition ( Krebber et al., 2014; Watts, Prescott, Mason, McLeod & Lewith, 2015; 
Walker et al., 2015). However, little is understood about cancer outcomes for people living 
with a mental illness. This literature review looks to systematically review the available 





Six electronic databases were searched for published research regarding cancer in people 
living with a mental illness. Twenty-eight papers were reviewed. The quality of each paper 
was evaluated using a standardised tool. 
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Findings 
 
Cancer is often diagnosed later in individuals with a mental illness. People with mental 
illness and cancer were less likely to use screening services or detect abnormal bodily 
symptoms. Furthermore, in some cases cancer was only found following an individual’s 
death. A number of studies highlighted that individuals with mental illness were less likely to 
receive specialist cancer care. This was sometimes due to the expressed preferences of the 
patient and at other times was due to a decision made by oncology clinicians. Exceptions to 
this, were found in veterans with cancer and mental illness. Veterans in these studies were 
treated in services, in the united states, where cancer and mental health were collaboratively 
cared for. Ultimately, the low rate of diagnosis and lack of treatment were found to lead to an 




People living with a mental illness and cancer experience poorer outcomes than the general 
population. However, the studies reviewed were mainly retrospective case file reviews. Thus, 
the link between cancer and mental health could be understood better if research was 
designed to collect data directly from people living with a mental illness and cancer, in 
addition to research that did not use historical data, but data collected in the present.    
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Empirical Paper: The Development of a Psychological Prehabilitation 




Sarcoma is a cancer that can be found in the soft tissue, bone and gastrointestinal system 
(Sarcoma UK, N.D). Sarcomas are often misdiagnosed, meaning they are larger by the time 
that they are diagnosed (Grimer, Judson, Peake & Seddon, 2010) and so treatment is needed 
urgently. The primary treatment for a sarcoma is surgery (Gerrand et al., 2016; Grimer, 
Judson, Peake & Seddon, 2010). This surgery can often be aggressive in nature and may 
require loss of body parts to remove the tumour (Shehadeh et al., 2013).  
 
The period between being diagnosed with a sarcoma and undergoing surgery can lead to 
depression and anxiety in patients (Paredes et al., 2011). This experience of anxiety and 
depression before surgery has been found to impact negatively on recovery after surgery 
(Broadbent, Petrie, Alley & Booth, 2003; Granot, Goldstein & Ferber, 2005).  
 
Prehabilitation, the act of offering a supportive therapy before a treatment, has been found to 
be beneficial for cancer patients before surgery (Tsimopoulou et al., 2015). Benefits of 
psychological prehabilitation include improvements in immunologic functioning, quality of 
life, fatigue, psychological outcomes (Tsimopoulou et al., 2015), pain, return to pre-surgery 
functioning and discharge from hospital (Powell et al., 2016). 
 
The present study looks to investigate if it is feasible to study the effectiveness of 




Nine people diagnosed with a sarcoma consented to participate in this study and were 
randomly allocated to either a control condition or an intervention condition. All participants 
were asked to complete six measures of physical and psychological wellbeing. Following 
this, the participants in the control condition received treatment as usual followed by their 
surgery. Those in the intervention arm received treatment as usual in addition to a one-hour 
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prehabilitation session with a psychologist, followed by their surgery. Four weeks after 
surgery all participants were asked to complete the same six outcome measures of physical 




It was found that study participants found the randomisation procedure acceptable. However, 
there were issues in receiving all the questionnaires back at the same time and so there is a 
risk that the data received for follow-up is not controlled, for the bias of time.  
 
A calculation was conducted to identify how many participants would need to be recruited in 
a larger study. The calculation predicted that one hundred and sixteen participants would 
need to be recruited for a future study to be powerful enough to find any difference between 
people allocated to the control group and intervention group. 
 
The outcome measures found that anxiety was in the “borderline abnormal” range (Zigmond 
& Snaith, 1983) but on most other measures participants appeared to be robust. After surgery 
all participants reported a decline in their ability to engage in domestic activities.  
 
Some participants showed a decline in physical and emotional wellbeing after surgery, whilst 





The findings suggest that it is feasible to conduct a study of prehabilitation for sarcoma 
patients in this setting.  The measures used appear to be appropriate as they were able to 
detect change. However, adaptions need to be made to the design in order to improve the 
controllability of the study.  
 
We can begin to predict that there is a need for prehabilitation for sarcoma patients, but only 
for a proportion of patients; the other proportion may not need an intensive psychological 
intervention but, rather, psychologically informed care to maintain their wellbeing, as was 
seen in this small sample.  
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Appendix 8 – Participant Information Sheet
 
 
 157  
 
 158  
 
 








 160  




 161  
Appendix 10 – Randomisation Procedure  
 
The chief investigator wrote down the word intervention eight times and the word control 
eight times. Following this the numbers one to sixteen were written down on 16 small 
pieces of paper. The numbers were then pulled out of a hat; the first eight were assigned to 
the intervention arm and the next set of numbers were assigned to the control arm. The 
numbers were then placed back into a hat. Once participants returned their consent forms 
and completed the questionnaire at time one, a number was pulled out of the hat, the chief 
investigator then consulted the previous record to see if this number was associated with 
the intervention or control arm. Participants were then made aware by telephone 
conversation which arm they had been randomised to. For those in the intervention arm the 
intervention was then scheduled.  
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Appendix 13 – Reflective Diary Extracts 
 
Diary Extract 1 
  
All the people I spoke with were really keen to participate and the conversations lasted less 
than 10 minutes. The part of the conversation that took the longest was reassuring 
participants about the timing of the intervention – despite having reassured them early in 
the conversation that the intervention would be tagged onto a date when they were already 
at the hospital. Those who I spoke to mainly wanted to reiterate that they could not have 
another journey due to the distance that they were travelling. I got the overwhelming sense 
that the distance that people were travelling was a burden. After being reassured that the 
intervention would be offered on the same day all participants were happy to receive 
further information. However,  it has now dawned on me that on the surface it appears that 
it would be beneficial to meet on the same day as a preoperative appointment, but actually 
this has the potential to become overwhelming. I can most certainly imagine that for myself 
this would be overwhelming. As part of my duty of care towards the people who may 
participate this is something I should take into account, as this intervention should make 
people feel cared for rather than adding another distressing appointment to attend. 
 
Diary Extract 2 
 
I arrived on the ward and looked amongst the beds for X name. Once I found X’s name I 
noticed a lady sat on the bed with a man to the side, I presumed this to be her partner. For a 
moment I thought about leaving and giving them some time. But with it already being 
5:30pm I could not leave it till much later to offer the intervention. So, I decided to 
introduce myself and check if X and the man needed 5 minutes. X and her husband (as I had 
now discovered) said they were fine, although X looked nervous. They then began to 
exchange items for X’s husband to take with him, with X saying, “I can’t take them to 
surgery with me”. It dawned on me that this was the last time they would see each other 
before X underwent surgery. They then kissed each other goodbye. I did an awkward half 
turn. X’s husband then left. For myself this was one of the top 10 most awkward situations I 
have encountered as a psychologist. I can’t imagine how it must have felt for X. What this 
highlighted to me was the importance of the timing of when this intervention was offered – 
whilst I am not sure what the literature says my instincts would tell me that a goodbye with 
family is a natural process which is just if not so more important than a psychological 
intervention. 
 
Diary Extract 3 
 
Generally, X commented on how the service at the hospital had been exemplary and she 
had been happy to be able to leave within less than a week. X did add that she had expected 
to see me before she left, to prepare her to go home. I wasn’t sure what to say. I didn’t feel 
as though I needed to apologise as I had not offered to do this, but I also wanted to 
understand the need more. X went on to explain that for her going home was quite scary 
because she was expected to get back to “normal life” when she did not feel normal. I said 
we would consider this when developing the research. 
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Diary 4 
 
Of all the people I spoke with today, I think at least one quarter made a statement to the 
effect of “anything to help others” when rationalising why they wanted to participate. This 
made me think of the drive behind cancer and how it puts an onus on each of us to do our 
bit to “beat” cancer. I have thought about how this fit with the descriptions we use of 
cancer “survive” “beat” “battling” and how this often gives us a sense of control. I wonder if 
for those who I spoke with today if thinking about how they can beat cancer as a whole for 
others gave them a sense of control maybe in a time when they were feeling less in control 
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Groups Participant Reliable Change Significance 











































Nottingham Extended Activities of Daily Living Scale 
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Warwick Edinburgh Mental Wellbeing Scale 
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Group Participant Reliable Change  Significance 








































Hospital Anxiety and Depression Scale 
 
Group Participant Subtest Reliable 
change 
Significance 




























































































Mini-Mental Adjustment to Cancer Scale 
 
Group Participant Subscale Reliable 
change 
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Compassionate Engagement and Action Scale – Self-Compassion 
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Change 
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